<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1-3.dtd?><?SourceDTD.Version 1.3?><?ConverterInfo.XSLTName jats2jats3.xsl?><?ConverterInfo.Version 1?><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Biomolecules</journal-id><journal-id journal-id-type="iso-abbrev">Biomolecules</journal-id><journal-id journal-id-type="publisher-id">biomolecules</journal-id><journal-title-group><journal-title>Biomolecules</journal-title></journal-title-group><issn pub-type="epub">2218-273X</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">10452555</article-id><article-id pub-id-type="doi">10.3390/biom13081191</article-id><article-id pub-id-type="publisher-id">biomolecules-13-01191</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Genus <italic toggle="yes">Acrostalagmus</italic>: A Prolific Producer of Natural Products</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-1394-3000</contrib-id><name><surname>Shi</surname><given-names>Ting</given-names></name><xref rid="af1-biomolecules-13-01191" ref-type="aff">1</xref><xref rid="af2-biomolecules-13-01191" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Han</given-names></name><xref rid="af1-biomolecules-13-01191" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Yan-Jing</given-names></name><xref rid="af1-biomolecules-13-01191" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Yi-Fei</given-names></name><xref rid="af1-biomolecules-13-01191" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Pan</surname><given-names>Qun</given-names></name><xref rid="af1-biomolecules-13-01191" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-4226-4963</contrib-id><name><surname>Wang</surname><given-names>Bo</given-names></name><xref rid="af1-biomolecules-13-01191" ref-type="aff">1</xref><xref rid="c1-biomolecules-13-01191" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Shang</surname><given-names>Er-Lei</given-names></name><xref rid="af3-biomolecules-13-01191" ref-type="aff">3</xref><xref rid="c1-biomolecules-13-01191" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Leychenko</surname><given-names>Elena</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-biomolecules-13-01191"><label>1</label>College of Chemical and Biological Engineering, Shandong University of Science and Technology, Qingdao 266590, China; <email>shiting_jia@126.com</email> (T.S.); <email>h15725209196@163.com</email> (H.W.); <email>15153232290@163.com</email> (Y.-J.L.); <email>kingsley11f115@163.com</email> (Y.-F.W.); <email>18663100496@163.com</email> (Q.P.)</aff><aff id="af2-biomolecules-13-01191"><label>2</label>State Key Laboratory of Microbial Technology, Institute of Microbial Technology, Shandong University, Qingdao 266237, China</aff><aff id="af3-biomolecules-13-01191"><label>3</label>School of Life Sciences, Shandong University, Qingdao 266237, China</aff><author-notes><corresp id="c1-biomolecules-13-01191"><label>*</label>Correspondence: <email>wb@sdust.edu.cn</email> (B.W.); <email>since2014eh@163.com</email> (E.-L.S.)</corresp></author-notes><pub-date pub-type="epub"><day>30</day><month>7</month><year>2023</year></pub-date><pub-date pub-type="collection"><month>8</month><year>2023</year></pub-date><volume>13</volume><issue>8</issue><elocation-id>1191</elocation-id><history><date date-type="received"><day>30</day><month>6</month><year>2023</year></date><date date-type="rev-recd"><day>26</day><month>7</month><year>2023</year></date><date date-type="accepted"><day>28</day><month>7</month><year>2023</year></date></history><permissions><copyright-statement>&#x000a9; 2023 by the authors.</copyright-statement><copyright-year>2023</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p><italic toggle="yes">Acrostalagmus</italic> is known for its ability to produce numerous bioactive natural products, making it valuable in drug development. This review provides information on the sources, distribution, chemical structure types, biosynthesis, and biological activities of the compounds isolated from the genus <italic toggle="yes">Acrostalagmus</italic> in the family <italic toggle="yes">Plectosphaerellaceae</italic> from 1969 to 2022. The results show that 50% of the compounds isolated from <italic toggle="yes">Acrostalagmus</italic> are new natural products, and 82% of the natural products derived from this genus are from the marine <italic toggle="yes">Acrostalagmus</italic>. The compounds isolated from <italic toggle="yes">Acrostalagmus</italic> exhibit diverse structures, with alkaloids being of particular importance, accounting for 56% of the natural products derived from this genus. Furthermore, within the alkaloid class, 61% belong to the epipolythiodioxopiperazine family, highlighting the significance of epipolythiodioxopiperazine as a key characteristic structure within <italic toggle="yes">Acrostalagmus</italic>. Seventy-two percent of natural products derived from <italic toggle="yes">Acrostalagmus</italic> display bioactivities, with 50% of the bioactive compounds exhibiting more significant or comparable activities than their positive controls. Interestingly, 89% of potent active compounds are derived from marine fungi, demonstrating their promising potential for development. These findings underscore <italic toggle="yes">Acrostalagmus</italic>, particularly the marine-derived genus <italic toggle="yes">Acrostalagmusas</italic>, a valuable source of new bioactive secondary metabolites, and emphasize the vast resource importance of the ocean.</p></abstract><kwd-group><kwd><italic toggle="yes">Acrostalagmus</italic></kwd><kwd>marine-derived fungi</kwd><kwd>secondary metabolites</kwd><kwd>epipolythiodioxopiperazine</kwd><kwd>bioactivities</kwd></kwd-group><funding-group><award-group><funding-source>National Natural Science Foundation of China</funding-source><award-id>82104029</award-id><award-id>21868011</award-id></award-group><award-group><funding-source>Talent Support Program of Shandong University of Science and Technology</funding-source></award-group><funding-statement>This research was funded by the National Natural Science Foundation of China (No. 82104029 and 21868011) and the Talent Support Program of Shandong University of Science and Technology in 2019&#x02013;2023.</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-biomolecules-13-01191"><title>1. Introduction</title><p><italic toggle="yes">Acrostalagmus</italic> is a genus of ascomycete fungi in the class <italic toggle="yes">Sordariomycetes</italic>, order <italic toggle="yes">Glomerellales</italic>, family <italic toggle="yes">Plectosphaerellaceae</italic>. There are four species (<italic toggle="yes">A. annulatus</italic>, <italic toggle="yes">A.</italic> cf. <italic toggle="yes">luteoalbus</italic>, <italic toggle="yes">A.</italic> cf. <italic toggle="yes">luteoalbus</italic> CK1, <italic toggle="yes">A. luteoalbus</italic>) of the genus <italic toggle="yes">Acrostalagmus</italic> in the National Center for Biotechnology Information (NCBI) database (<uri xlink:href="https://www.ncbi.nlm.nih.gov/data-hub/taxonomy/tree/?taxon=461148">https://www.ncbi.nlm.nih.gov/data-hub/taxonomy/tree/?taxon=461148</uri> (accessed on 27 July 2023)). The colony of <italic toggle="yes">Acrostalagmus</italic> is brick red, because of its red spores, with white mycelium at edge. The mass production of spores causes the overall colony to present a ring pattern with different shades. With the extension of culture time, the color gradually deepened and darkened, showing rust red [<xref rid="B1-biomolecules-13-01191" ref-type="bibr">1</xref>].</p><p>Most of the fungi belonging to the genus <italic toggle="yes">Acrostalagmus</italic> are alkalitolerant [<xref rid="B2-biomolecules-13-01191" ref-type="bibr">2</xref>,<xref rid="B3-biomolecules-13-01191" ref-type="bibr">3</xref>] or alkalophilic [<xref rid="B4-biomolecules-13-01191" ref-type="bibr">4</xref>] fungi, and are widely distributed in different ecological environments, including forest [<xref rid="B5-biomolecules-13-01191" ref-type="bibr">5</xref>], sand ridge state [<xref rid="B6-biomolecules-13-01191" ref-type="bibr">6</xref>], marine [<xref rid="B7-biomolecules-13-01191" ref-type="bibr">7</xref>,<xref rid="B8-biomolecules-13-01191" ref-type="bibr">8</xref>] and polar ecosystems [<xref rid="B9-biomolecules-13-01191" ref-type="bibr">9</xref>]. The genus <italic toggle="yes">Acrostalagmus</italic> can survive in different circumstances due to its ability to produce kinds of enzymes [<xref rid="B10-biomolecules-13-01191" ref-type="bibr">10</xref>,<xref rid="B11-biomolecules-13-01191" ref-type="bibr">11</xref>,<xref rid="B12-biomolecules-13-01191" ref-type="bibr">12</xref>] and secondary metabolites [<xref rid="B13-biomolecules-13-01191" ref-type="bibr">13</xref>] with a variety of bioactivities [<xref rid="B6-biomolecules-13-01191" ref-type="bibr">6</xref>,<xref rid="B14-biomolecules-13-01191" ref-type="bibr">14</xref>,<xref rid="B15-biomolecules-13-01191" ref-type="bibr">15</xref>]. The crude extracts of some <italic toggle="yes">Acrostalagmus</italic> species exhibited significant brine shrimp lethality, as well as antibacterial, antifungal and DPPH radical scavenging activities [<xref rid="B9-biomolecules-13-01191" ref-type="bibr">9</xref>,<xref rid="B16-biomolecules-13-01191" ref-type="bibr">16</xref>], meaning they have potential to produce abundant natural products with remarkable activities. Gas chromatography mass (GC-MS) [<xref rid="B17-biomolecules-13-01191" ref-type="bibr">17</xref>], high-performance liquid chromatography (HPLC)-electrospray ionization (ESI)-MS [<xref rid="B18-biomolecules-13-01191" ref-type="bibr">18</xref>], and ultra-HPLC-MS/MS spectrometry [<xref rid="B9-biomolecules-13-01191" ref-type="bibr">9</xref>] have been used to analyze the secondary metabolites of the genus <italic toggle="yes">Acrostalagmus</italic> and further demonstrate the great ability of this genus to produce bioactive compounds. To date, there has been no summary reviewing the natural products of the <italic toggle="yes">Acrostalagmus</italic> genus. In consideration of the above-mentioned facts, the chemical structure types, sources, distribution, biological activities, and biological synthesis of the compounds isolated from <italic toggle="yes">Acrostalagmus</italic> from 1969 to 2022 are comprehensively reviewed in this paper.</p></sec><sec id="sec2-biomolecules-13-01191"><title>2. Terpenoids</title><p>The first research on the secondary metabolites isolated from the genus <italic toggle="yes">Acrostalagmus</italic> was performed in 1969 by George A. Ellestad et al. [<xref rid="B19-biomolecules-13-01191" ref-type="bibr">19</xref>]. Two norditerpenes, named LL-Z1271&#x003b1; (<bold>1</bold>) and LL-Z1271&#x003b3; (<bold>2</bold>) (<xref rid="biomolecules-13-01191-f001" ref-type="fig">Figure 1</xref>), were isolated from an unidentified <italic toggle="yes">Acrostalagmus</italic> sp. NRRL-3481 [<xref rid="B19-biomolecules-13-01191" ref-type="bibr">19</xref>,<xref rid="B20-biomolecules-13-01191" ref-type="bibr">20</xref>]. In 1971, one norditerpene analogue, LL-Z1271&#x003b2; (<bold>3</bold>), was discovered from the same species by the same research group [<xref rid="B21-biomolecules-13-01191" ref-type="bibr">21</xref>]. In 1974, three other analogs <bold>4</bold>&#x02013;<bold>6</bold> were obtained from the culture of <italic toggle="yes">Acrostalagmus</italic> NRRL-3481 [<xref rid="B22-biomolecules-13-01191" ref-type="bibr">22</xref>]. Terpenoids <bold>1</bold>&#x02013;<bold>6</bold> were deduced to be biosynthesized from microbiological degradation of a diterpene, such as labdadienol, through oxidative cleavage between C-12 and C-13 [<xref rid="B22-biomolecules-13-01191" ref-type="bibr">22</xref>] (<xref rid="biomolecules-13-01191-f002" ref-type="fig">Figure 2</xref>). The absolute configuration of <bold>4</bold> at the location of C-8 was deduced to be 8<italic toggle="yes">R</italic> according to the supposed biosynthesis pathway from compound <bold>6</bold> to <bold>4</bold>. Compound <bold>1</bold> displayed remarkable antifungal activity in vitro against kinds of fungi and in vivo against some experimental ringworm infections in guinea pigs [<xref rid="B19-biomolecules-13-01191" ref-type="bibr">19</xref>]. Additionally, <bold>1</bold> displayed effectiveness against the fungi that cause infection in humans with the minimum inhibitory concentrations (MICs) against <italic toggle="yes">Cryptococcus neoformans</italic> and <italic toggle="yes">Candida albicans</italic> of 2 &#x000b5;g/mL and 8 &#x000b5;g/mL, respectively [<xref rid="B23-biomolecules-13-01191" ref-type="bibr">23</xref>]. Compound <bold>1</bold> was the inhibitor of <italic toggle="yes">Pseudogymnoascus destructans</italic>, which is the fungus that leads to a devastating disease of hibernating bats named white-nose syndrome (WNS), with an MIC value of 15 &#x003bc;g/mL [<xref rid="B24-biomolecules-13-01191" ref-type="bibr">24</xref>]. The cytotoxicity of <bold>1</bold> against the murine P388 lymphocytic leukemia cell line and a series of human cancer cell lines were evaluated and IC<sub>50</sub> values ranging from 0.14 to 4.1 &#x000b5;g/mL [<xref rid="B23-biomolecules-13-01191" ref-type="bibr">23</xref>] were obtained. Compound <bold>3</bold> also showed cytotoxic activity against human cancer cell line HL-60 with an IC<sub>50</sub> value of 0.60 &#x000b5;M, with the same level as the positive control epirubicin (IC<sub>50</sub> = 0.71 &#x000b5;M) [<xref rid="B25-biomolecules-13-01191" ref-type="bibr">25</xref>]. Compound <bold>1</bold>, as a plant growth regulator, showed significant inhibitory activity on the growth of an <italic toggle="yes">Avena coleoptile</italic> section comparable to those of structural analogues, inumakilactones, nagilactones, and podolactones, which showed strong inhibitory activity to the expansion and mitosis of plant cell [<xref rid="B26-biomolecules-13-01191" ref-type="bibr">26</xref>]. At a concentration of 10<sup>&#x02212;4</sup> M, Compound <bold>1</bold> significantly inhibited the germination and growth development of three plant species: two monocotyledons (<italic toggle="yes">Allium cepa</italic> and <italic toggle="yes">Hordeum vulgare</italic>) and one dicotyledon (<italic toggle="yes">Lactuca sativa</italic>), with an inhibition rate of over 80%, which is more active than the commercial herbicide LOGRAN<sup>&#x000ae;</sup>, indicating that <bold>1</bold> shows potential as a herbicide template and may serve as a next generation of natural agrochemicals [<xref rid="B27-biomolecules-13-01191" ref-type="bibr">27</xref>]. Compound <bold>1</bold> displayed potent inhibitory activity to the production of IL-1&#x003b2; (interleukin-1&#x003b2;, a proinflammatory cytokine produced primarily by macrophages and monocytes in answer to various stimuli [<xref rid="B28-biomolecules-13-01191" ref-type="bibr">28</xref>]) in the manner of dose-dependent application with an IC<sub>50</sub> value of 0.049 &#x003bc;M in human whole blood [<xref rid="B29-biomolecules-13-01191" ref-type="bibr">29</xref>,<xref rid="B30-biomolecules-13-01191" ref-type="bibr">30</xref>]. Compound <bold>1</bold> exhibited a much weaker inhibitory effect on leucine uptake than on IL-1&#x003b2; production which suggests that the compound&#x02019;s action is not a result of general effects on protein synthesis. The inhibition mechanism of <bold>1</bold> is also not because of the ATP-induced release, effects on caspase-1, or a lysosomotrophic effect [<xref rid="B29-biomolecules-13-01191" ref-type="bibr">29</xref>]. Further research on the target for <bold>1</bold> is in progress, which may identify a mechanistically new approach for the treatment of IL-1&#x003b2; associated diseases [<xref rid="B29-biomolecules-13-01191" ref-type="bibr">29</xref>].</p></sec><sec id="sec3-biomolecules-13-01191"><title>3. Alkaloids</title><p>Melinacidin, a mixture of at least four closely related compounds obtained from the culture broth of the fungus <italic toggle="yes">Acrostalagmus cinnabarinus</italic> var. <italic toggle="yes">melinacidinus</italic>, was first discovered in 1968 and showed antibacterial activity against various of Gram-positive bacteria in vitro [<xref rid="B31-biomolecules-13-01191" ref-type="bibr">31</xref>]. However, melinacidin was ineffective in protecting mice from the infection of <italic toggle="yes">Staphylococcus aureus</italic> when administered subcutaneously at the maximum tolerated dose of 1 mg/mL [<xref rid="B31-biomolecules-13-01191" ref-type="bibr">31</xref>]. The mechanism of antibacterial activity of melinacidin was studied and found to be blocked the synthesis of nicotinic acid and its amide in <italic toggle="yes">Bacillus subtilis</italic> cells. The biosynthetic pathway leading to nicotinic acid was interfered with by melinacidin before the formation of quinolinic acid [<xref rid="B32-biomolecules-13-01191" ref-type="bibr">32</xref>]. The antifungal activity of melinacidin was only exhibited on <italic toggle="yes">nocardia asteroides</italic> and <italic toggle="yes">Blastomyces dermatitidis</italic> with MIC values of 10 and 1000 &#x003bc;g/mL, respectively. Melinacidin displayed inhibition of the growth of KB cells in tissue cultures with an ID<sub>50</sub> (50% inhibition of protein synthesis) value of 0.014 &#x003bc;g/mL and had marginal in vivo activity in mice infected with Herpes virus [<xref rid="B31-biomolecules-13-01191" ref-type="bibr">31</xref>]. In 1972, melinacidin was separated into three compounds, melinacidins II, III, and IV (<bold>7</bold>&#x02013;<bold>9</bold>), and their structure characterizations were described [<xref rid="B33-biomolecules-13-01191" ref-type="bibr">33</xref>]. While the certain structures of <bold>7</bold>&#x02013;<bold>9</bold> were finally determined in 1977 to be epipolythiodioxopiperazines (ETPs) (<xref rid="biomolecules-13-01191-f003" ref-type="fig">Figure 3</xref>) [<xref rid="B34-biomolecules-13-01191" ref-type="bibr">34</xref>]. Compound <bold>9</bold> showed potent cytotoxicity against murine P388 leukemia cells with an IC<sub>50</sub> value of 0.05 &#x000b5;M [<xref rid="B35-biomolecules-13-01191" ref-type="bibr">35</xref>]. Compound <bold>9</bold> also exhibited antibacterial activities against methicillin-resistant <italic toggle="yes">S. aureus</italic> (MRSA) and vancomycin-resistant <italic toggle="yes">Enterococcus faecium</italic> (VRE) with the MIC values of 0.7 and 22 &#x003bc;g/mL, respectively. The antibacterial activity of <bold>9</bold> to MRSA exhibited double the activity of the positive control vancomycin (MIC = 1.4 &#x000b5;g/mL) [<xref rid="B36-biomolecules-13-01191" ref-type="bibr">36</xref>].</p><p>Chemical investigation of the deep-sea sediment-derived fungus <italic toggle="yes">A. luteoalbus</italic> SCSIO F457 led to the isolation of two new indole diketopiperazines, luteoalbusins A and B (<bold>10</bold> and <bold>11</bold>), as well as eight known diketopiperazines, T988A (<bold>12</bold>), gliocladines C and D (<bold>13</bold> and <bold>14</bold>), chetoseminudins B and C (<bold>15</bold> and <bold>16</bold>) (<xref rid="biomolecules-13-01191-f003" ref-type="fig">Figure 3</xref>), cyclo(L-Trp-L-Ser) (<bold>35</bold>), cyclo(L-Trp-L-Ala) (<bold>36</bold>), and cyclo(L-Trp-<italic toggle="yes">N</italic>-methyl-L-Ala) (<bold>37</bold>) [<xref rid="B37-biomolecules-13-01191" ref-type="bibr">37</xref>]. The bi-indole diketopiperazines (<bold>10</bold>&#x02013;<bold>14</bold>) exhibited potent cytotoxicity against four cancer cell lines, SF-268, MCF-7, NCI-H460, and HepG-2, with IC<sub>50</sub> values ranging from 0.23 to 17.78 &#x000b5;M. The new compounds <bold>10</bold> and <bold>11</bold> showed stronger cytotoxicity against all four tested cancer cell lines than that of the positive control cisplatin [<xref rid="B37-biomolecules-13-01191" ref-type="bibr">37</xref>]. Compounds <bold>10</bold> and <bold>11</bold> also displayed prominent cytotoxic activities against A549, HeLa, and HCT116 cancer cell lines with IC<sub>50</sub> values ranging from 0.52 to 2.33 &#x000b5;M [<xref rid="B42-biomolecules-13-01191" ref-type="bibr">42</xref>]. Compound <bold>12</bold> was first discovered from a decaying wood derived fungus <italic toggle="yes">Tilachlidium</italic> sp. CANU-T988, and displayed cytotoxicity to P388 leukemia cells with an IC<sub>50</sub> value of 0.25 &#x000b5;M [<xref rid="B43-biomolecules-13-01191" ref-type="bibr">43</xref>]. Compounds <bold>13</bold> and <bold>14</bold> were first isolated from the submerged wood derived fungus <italic toggle="yes">Gliocladium roseum</italic> 1A and showed nematicidal activities toward <italic toggle="yes">Caenorhabditis elegans</italic> and <italic toggle="yes">Panagrellus redivivus</italic> with ED<sub>50</sub> (concentrations causing more than 50% mortality after 24 h) values of 200/250 and 200/250 &#x000b5;g/mL, respectively [<xref rid="B44-biomolecules-13-01191" ref-type="bibr">44</xref>]. Compounds <bold>10</bold> and <bold>13</bold> were exhibited antimicrobial activities against <italic toggle="yes">Canidia albicans</italic> and <italic toggle="yes">Aeromonas salmonicida</italic> with MIC values of 12.5/12.5 (<bold>10</bold>) and 25/50 (<bold>13</bold>) &#x000b5;M, respectively [<xref rid="B9-biomolecules-13-01191" ref-type="bibr">9</xref>]. Compounds <bold>15</bold> and <bold>16</bold> were first found from the fungus <italic toggle="yes">Chaetomium seminudum</italic> 72-S-204-1, and <bold>15</bold> showed weak immunosuppressive activity with an IC<sub>50</sub> value of 24 &#x000b5;g/mL on Con A-induced (T-cells) proliferations of mouse splenic lymphocytes [<xref rid="B45-biomolecules-13-01191" ref-type="bibr">45</xref>]. Compounds <bold>15</bold> and <bold>16</bold> exhibited potent cytotoxic activities against murine lymphoma L5178Y cell line with EC<sub>50</sub> values of 0.26 and 0.82 &#x000b5;M, respectively, which are more potent than that of the positive control kahalalide F (EC<sub>50</sub> = 4.3 &#x000b5;M) [<xref rid="B46-biomolecules-13-01191" ref-type="bibr">46</xref>]. Compound <bold>15</bold> also showed obvious enzyme inhibition against mushroom tyrosinase with an IC<sub>50</sub> value of 31.7 &#x000b1; 0.2 &#x000b5;M, which is stronger than the inhibitory activity of the positive control kojic acid (IC<sub>50</sub> = 40.4 &#x000b1; 0.1 &#x003bc;M) [<xref rid="B47-biomolecules-13-01191" ref-type="bibr">47</xref>].</p><p>Two new epipolythiodioxopiperazines (ETPs), chetracins E and F (<bold>17</bold> and <bold>18</bold>), as well as one known congener, chetracin C (<bold>19</bold>), were isolated from the culture extract of <italic toggle="yes">A. luteoalbus</italic> HDN13-530, a fungus obtained from the soil of Liaodong Bay [<xref rid="B38-biomolecules-13-01191" ref-type="bibr">38</xref>]. Compounds <bold>17</bold>&#x02013;<bold>19</bold> displayed extensive cytotoxic activities toward a series of cancer cell lines A549, HCT116, K562, H1975 and HL-60 with the IC<sub>50</sub> values ranging from 0.2 to 2.1 &#x000b5;M, and <bold>17</bold> even showed stronger cytotoxicity to H1975 cancer cell line with an IC<sub>50</sub> value of 0.2 &#x000b5;M than that of positive drug doxorubicin hydrochloride (IC<sub>50</sub> = 0.8 &#x000b5;M) [<xref rid="B38-biomolecules-13-01191" ref-type="bibr">38</xref>]. One of the reasons <bold>17</bold>&#x02013;<bold>19</bold> cytotoxicity is possible due their ability to reduce the expressions of Akt, EGFR, and the active forms of Akt, EGFR, Erk, and Stat3 (Hsp90 client oncoproteins) in H1975 cells at the concentration of 0.5 &#x000b5;M, indicating their inhibition to C-terminal Hsp90 [<xref rid="B38-biomolecules-13-01191" ref-type="bibr">38</xref>]. Compound <bold>19</bold> was first isolated from Antarctic soil derived fungus <italic toggle="yes">Oidiodendron truncatum</italic> GW3-13 and showed significant cytotoxicity against a panel of the cancer cell lines HCT-8, Bel-7402, BGC-823, and A2780 with IC<sub>50</sub> values that ranged 0.49&#x02013;0.70 &#x000b5;M [<xref rid="B48-biomolecules-13-01191" ref-type="bibr">48</xref>].</p><p>Three pairs of new <italic toggle="yes">N</italic>-methoxy-indolediketopiperazines enantiomers, (&#x000b1;)-acrozines A&#x02013;C (<bold>20</bold>&#x02013;<bold>25</bold>, <xref rid="biomolecules-13-01191-f003" ref-type="fig">Figure 3</xref>), were isolated from the marine green alga <italic toggle="yes">Codium fragile</italic> derived endophytic fungus <italic toggle="yes">A. luteoalbus</italic> TK-43 [<xref rid="B39-biomolecules-13-01191" ref-type="bibr">39</xref>]. Four new acrozine-type indolediketopiperazines, acrozines D&#x02013;G (<bold>26</bold>&#x02013;<bold>29</bold>, <xref rid="biomolecules-13-01191-f003" ref-type="fig">Figure 3</xref>), along with six known analogues, pseudellone D (<bold>30</bold>), lasiodipline E (<bold>31</bold>), chetoseminudins B and C (<bold>15</bold> and <bold>16</bold>), T988 C and B (<bold>32</bold> and <bold>33</bold>) (<xref rid="biomolecules-13-01191-f003" ref-type="fig">Figure 3</xref>), were isolated from the culture extract of the same fungal species TK-43 [<xref rid="B40-biomolecules-13-01191" ref-type="bibr">40</xref>]. Compounds <bold>15</bold>, <bold>16,</bold> and <bold>20</bold>&#x02013;<bold>33</bold> were evaluated for their antimicrobial activities toward 15 plant pathogenic fungi, one human pathogenic bacterium, and 10 aquatic pathogens. Only (&#x02013;)-acrozine B (<bold>23</bold>) showed antifungal activity toward the plant pathogen <italic toggle="yes">Fusarium solani</italic> with an MIC value of 32 &#x003bc;g/mL, which is stronger than the activities of its enantiomer <bold>22</bold> and its epimers <bold>20</bold> and <bold>21</bold> (MIC &#x0003e; 64 &#x003bc;g/mL) [<xref rid="B39-biomolecules-13-01191" ref-type="bibr">39</xref>]. These results indicate that the absolute configurations of 3<italic toggle="yes">R</italic>, 6<italic toggle="yes">R</italic> are the key structures to producing antifungal activity. While compound <bold>25</bold> with the same configurations of 3<italic toggle="yes">R</italic>, 6<italic toggle="yes">R</italic> had no antifungal activity, this might suggest the significance of methylene hydroxyl and thiomethyl groups located at C-3 and C-6, respectively, for the antifungal activity. Compounds <bold>30</bold> and <bold>16</bold> showed antibacterial activity against <italic toggle="yes">Edwardsiella icataluri</italic> with MIC values of 3 and 5 &#x003bc;M, respectively, which are comparable to that of the positive control, chloromycetin (MIC = 2 &#x003bc;M) [<xref rid="B40-biomolecules-13-01191" ref-type="bibr">40</xref>]. Compound <bold>32</bold> showed broad-spectrum antibacterial activity and demonstrated more potent activity (MIC = 2 &#x003bc;M) against <italic toggle="yes">Vibrio parphemolyticus</italic> than the positive control chloromycetin (MIC = 12 &#x003bc;M) [<xref rid="B40-biomolecules-13-01191" ref-type="bibr">40</xref>]. The antimicrobial activity of <bold>32</bold> against <italic toggle="yes">Candida albicans</italic> (MIC = 6.25 &#x003bc;M) and <italic toggle="yes">Aeromonas salmonicida</italic> (MIC = 3.125 &#x003bc;M) were comparable to that of positive control ciprofloxacin (MIC = 6.25 &#x003bc;M) [<xref rid="B9-biomolecules-13-01191" ref-type="bibr">9</xref>]. The results indicate that antibacterial activities are significantly reduced (from <bold>30</bold> and <bold>16</bold> to <bold>20</bold>&#x02013;<bold>29</bold>, <bold>31</bold>, and <bold>15</bold>) when there is a methoxy or methyl substitution at <italic toggle="yes">N</italic>-2. Additionally, antibacterial activity is significantly increased when there is a disulfide bridge (from <bold>33</bold> to <bold>32</bold>) [<xref rid="B39-biomolecules-13-01191" ref-type="bibr">39</xref>,<xref rid="B40-biomolecules-13-01191" ref-type="bibr">40</xref>]. Compound <bold>31</bold> was first discovered from the culture of <italic toggle="yes">Illigera rhodantha</italic> (a flower belongs to Hernandiaceae) derived endophytic fungus <italic toggle="yes">Lasiodiplodia pseudotheobromae</italic> F2, and exhibited strong antibacterial activity toward the clinical strains <italic toggle="yes">Bacteroides vulgates</italic>, <italic toggle="yes">Streptococcus</italic> sp., <italic toggle="yes">Veillonella parvula,</italic> and <italic toggle="yes">Peptostreptococcus</italic> sp., with an MIC value range of 0.12&#x02013;0.25 &#x003bc;g/mL, comparable or even more significant than that of positive control tinidazole (MIC values range of 0.12&#x02013;0.5 &#x003bc;g/mL) [<xref rid="B49-biomolecules-13-01191" ref-type="bibr">49</xref>]. T988 A and C (<bold>12</bold> and <bold>32</bold>) showed potent antibacterial activities against <italic toggle="yes">S. aureus</italic>, methicillin-resistant <italic toggle="yes">S. aureus</italic>, and <italic toggle="yes">S. pyogenes</italic> with IC<sub>50</sub> values of 3.8/5.8, 8.4/5.6, and 1.8/3.1 &#x003bc;M, respectively. It was demonstrated that <bold>12</bold> and <bold>32</bold> exhibited antibacterial synergy in combination with ciprofloxacin, ampicillin, and streptomycin [<xref rid="B50-biomolecules-13-01191" ref-type="bibr">50</xref>]. The biofilm inhibition caused by <bold>12</bold> and <bold>32</bold> in <italic toggle="yes">S. aureus</italic> and <italic toggle="yes">S. pyogenes</italic> was approximately 70% at their MIC and over 60% at one-sixteenth of their MIC, respectively [<xref rid="B50-biomolecules-13-01191" ref-type="bibr">50</xref>]. The mechanism of antibacterial activity in compounds <bold>12</bold> and <bold>32</bold> was explored and it was found that they have the ability to inhibit bacterial transcription/translation in vitro and inhibit the production of staphyloxanthin in <italic toggle="yes">S. aureus</italic> [<xref rid="B50-biomolecules-13-01191" ref-type="bibr">50</xref>].</p><p>Compounds <bold>20</bold>&#x02013;<bold>29</bold> were tested for their anti-acetylcholinesterase (AChE) activity. (&#x000b1;)-Acrozines A had medium anti-AChE activity with IC<sub>50</sub> value of 9.5 &#x003bc;M, and the chiral split compound, (+)-acrozine A (<bold>20</bold>) (IC<sub>50</sub> = 2.3 &#x003bc;M) displayed better inhibition than that of (&#x02013;)-acrozine A (<bold>21</bold>) (IC<sub>50</sub> = 13.8 &#x003bc;M) and (&#x000b1;)-acrozines A [<xref rid="B39-biomolecules-13-01191" ref-type="bibr">39</xref>]. Compound <bold>26</bold>, which has the same planar structure and different configurations as that of <bold>24</bold> (IC<sub>50</sub> = 160.6 &#x003bc;M) and <bold>25</bold> (IC<sub>50</sub> = 121.7 &#x003bc;M), displayed much better AChE inhibitory activity with IC<sub>50</sub> value of 18.9 &#x003bc;M [<xref rid="B39-biomolecules-13-01191" ref-type="bibr">39</xref>,<xref rid="B40-biomolecules-13-01191" ref-type="bibr">40</xref>]. These bioactivity data showed that compounds with identical planar structure may display different bioactivity and that the selectivity of biological activity is associated with the absolute configuration. Compound <bold>28</bold> showed anti-AChE activity with an IC<sub>50</sub> value of 8.4 &#x003bc;M [<xref rid="B40-biomolecules-13-01191" ref-type="bibr">40</xref>]. Compound <bold>28</bold> differs from (+)-acrozine B (<bold>22</bold>) (IC<sub>50</sub> = 78.8 &#x003bc;M) [<xref rid="B39-biomolecules-13-01191" ref-type="bibr">39</xref>] solely in the location of SCH<sub>3</sub> substitution, indicating the SCH<sub>3</sub> group at C-3 in <bold>28</bold> is more active than the SCH<sub>3</sub> group at C-6 in <bold>22</bold>.</p><p>The biosynthetic pathway for compounds <bold>7</bold>&#x02013;<bold>33</bold> is speculated as shown in <xref rid="biomolecules-13-01191-f004" ref-type="fig">Figure 4</xref>. Diketopiperazines <bold>7</bold>&#x02013;<bold>33</bold> are biosynthesized through non-ribosomal the peptide synthetase (NRPS) pathway [<xref rid="B51-biomolecules-13-01191" ref-type="bibr">51</xref>], and their biosynthetic precursors might be L-Trp and L-Ala (<bold>7</bold>, <bold>13</bold>, <bold>14</bold>, <bold>17</bold>, <bold>24</bold>&#x02013;<bold>26</bold> and <bold>29</bold>&#x02013;<bold>31</bold>), or L-Trp and L-Ser (<bold>7</bold>&#x02013;<bold>12</bold>, <bold>15</bold>&#x02013;<bold>23</bold>, <bold>27</bold>, <bold>28</bold>, <bold>32</bold> and <bold>33</bold>) [<xref rid="B40-biomolecules-13-01191" ref-type="bibr">40</xref>,<xref rid="B52-biomolecules-13-01191" ref-type="bibr">52</xref>]. The sulfurs are proposed to be incorporated into the cyclopeptide frameworks (<bold>7</bold>&#x02013;<bold>19</bold>, <bold>21</bold>&#x02013;<bold>23</bold> and <bold>28</bold>&#x02013;<bold>33</bold>) by CYP450 monooxygenase and a specialized glutathione <italic toggle="yes">S</italic>-transferase which is similar to that in gliotoxin (GT) [<xref rid="B48-biomolecules-13-01191" ref-type="bibr">48</xref>,<xref rid="B51-biomolecules-13-01191" ref-type="bibr">51</xref>,<xref rid="B53-biomolecules-13-01191" ref-type="bibr">53</xref>,<xref rid="B54-biomolecules-13-01191" ref-type="bibr">54</xref>], and the intramolecular disulfides are generated by FAD-dependent oxidoreductase, GliT, with dithiol precursors [<xref rid="B55-biomolecules-13-01191" ref-type="bibr">55</xref>].</p><p>Using the one strain many compounds (OSMAC) strategy to study the chemical diversity of <italic toggle="yes">A. luteoalbus</italic> SCSIO F457 led to one indole alkaloid, 3-(hydroxy-acetyl)-1<italic toggle="yes">H</italic>-indole (<bold>34</bold>, <xref rid="biomolecules-13-01191-f003" ref-type="fig">Figure 3</xref>); five cyclic dipeptides, cyclo(L-Phe-L-Pro) (<bold>38</bold>), cyclo(L-Tyr-L-Pro) (<bold>39</bold>), cyclo(L-Val-L-Pro) (<bold>40</bold>), cyclo(D-Ile-L-Pro) (<bold>41</bold>), and cyclo(D-Leu-L-Pro) (<bold>42</bold>); one pyranone derivative, 3-methoxy-2-methyl-4<italic toggle="yes">H</italic>-pyran-4-one (<bold>43</bold>); one benzo-tetrahydrofuran-lignin, paulownin (<bold>47</bold>); and three benzene derivatives, 1-methyoxy-4-(2-hydroxy)ethylbenzene (<bold>48</bold>), 2-(4-hydroxyphenyl)-ethanol (<bold>49</bold>), 1-phenylbutane-2,3-diol (<bold>50</bold>) [<xref rid="B41-biomolecules-13-01191" ref-type="bibr">41</xref>].</p></sec><sec id="sec4-biomolecules-13-01191"><title>4. Others</title><sec id="sec4dot1-biomolecules-13-01191"><title>4.1. Cyclic Dipeptides</title><p>Three known cyclo-dipeptides; cyclo(L-Trp-L-Ser) (<bold>35</bold>), cyclo(L-Trp-L-Ala) (<bold>36</bold>), and cyclo(L-Trp-<italic toggle="yes">N</italic>-methyl-L-Ala) (<bold>37</bold>) (<xref rid="biomolecules-13-01191-f005" ref-type="fig">Figure 5</xref>), were isolated from the culture extract of the deep-sea sediment-derived fungus <italic toggle="yes">A. luteoalbus</italic> SCSIO F457 [<xref rid="B37-biomolecules-13-01191" ref-type="bibr">37</xref>]. Although <bold>35</bold>&#x02013;<bold>37</bold> showed no cytotoxic activities against cancer cell lines MCF-7, SF-268, HepG-2, and NCI-H460 with the SRB method [<xref rid="B37-biomolecules-13-01191" ref-type="bibr">37</xref>], compound <bold>35</bold> displayed antimicrobial activity against <italic toggle="yes">Escherichia coli</italic>, <italic toggle="yes">Chromobacterium violaceum</italic> CV026, <italic toggle="yes">Pseudomonas aeruginosa</italic> PA01, <italic toggle="yes">S. aureus</italic> and <italic toggle="yes">C. albicans</italic> 00147 with the MIC values of 6.4, 3.2, 6.4, 3.2 and 6.4 mg/mL, respectively. Furthermore, <bold>35</bold> showed anti-quorum sensing (anti-QS) activity by inhibiting the production of violacein in <italic toggle="yes">C. violaceum</italic> CV026 with an inhibition of 67% in 0.2 mg/mL (the production inhibition of positive control azithromycin (AZM) was 80% in 0.05 mg/mL). The anti-QS activity of <bold>35</bold> was further confirmed by its reduction in elastase activity and biofilm formation. The reduced elastase activity in <bold>35</bold> was 40%, comparable with the positive control AZM, which induced a 49% inhibition. Interestingly, <bold>35</bold> resulted in a 59.9% reduction in biofilm formation in <italic toggle="yes">P. aeruginosa</italic> PA01 at a concentration of 0.2 mg/mL, which was better than the positive control AZM (53.9% reduction). Compound <bold>35</bold> or its derivatives can serve as leading compounds in the development of new antimicrobial drugs for clinical or agricultural research, playing a vital role in human health and agricultural development [<xref rid="B56-biomolecules-13-01191" ref-type="bibr">56</xref>,<xref rid="B57-biomolecules-13-01191" ref-type="bibr">57</xref>]. Compound <bold>35</bold> exhibited enzyme inhibition against <italic toggle="yes">&#x003b1;</italic>-glucosidase (AGS) with an IC<sub>50</sub> value of 164.5 &#x000b1; 15.5 &#x000b5;M, stronger than that of the positive control acarbose (IC<sub>50</sub> = 422.3 &#x000b1; 8.44 &#x000b5;M). In addition, <bold>35</bold> showed no cytotoxicity to the human normal hepatocyte (LO2) cells, suggesting its safety to be developed into hypoglycemic agent [<xref rid="B58-biomolecules-13-01191" ref-type="bibr">58</xref>]. Compound <bold>36</bold> showed antibacterial activity against <italic toggle="yes">Bacillus cereus</italic> and <italic toggle="yes">Proteus vulgaris</italic> with MIC values of 1.56 and 3.13 &#x000b5;M (the MIC of positive control ciprofloxacin was 0.78 and 0.20 &#x000b5;M) [<xref rid="B59-biomolecules-13-01191" ref-type="bibr">59</xref>]. The brine shrimp lethality of <bold>36</bold> was modest with an LD<sub>50</sub> value of 25.5 &#x000b5;M (the LD<sub>50</sub> of the positive control colchicine was 19.4 &#x000b5;M) [<xref rid="B60-biomolecules-13-01191" ref-type="bibr">60</xref>]. Compound <bold>36</bold> exhibited 54.6 &#x000b1; 0.6% cation radical (ABTS<sup>+&#x02022;</sup>) scavenging capacity at 2 mg/mL (the positive control vitamin C displayed 79.1 &#x000b1; 4.3% cation radical scavenging capacity at 0.16 mg/mL) [<xref rid="B61-biomolecules-13-01191" ref-type="bibr">61</xref>]. Furthermore, <bold>36</bold> also showed potent anti-diatom attachment activity at the concentration of 50 &#x000b5;g/mL with an inhibition of 85% [<xref rid="B62-biomolecules-13-01191" ref-type="bibr">62</xref>].</p><p>Further investigation of the chemical structure diversity of the fungus <italic toggle="yes">A. luteoalbus</italic> SCSIO F457, using the strategy of OSMAC, led to another five cyclic dipeptides: cyclo(L-Phe-L-Pro) (<bold>38</bold>), cyclo(L-Tyr-L-Pro) (<bold>39</bold>), cyclo(L-Val-L-Pro) (<bold>40</bold>), cyclo(D-Ile-L-Pro) (<bold>41</bold>), and cyclo(D-Leu-L-Pro) (<bold>42</bold>) (<xref rid="biomolecules-13-01191-f005" ref-type="fig">Figure 5</xref>) [<xref rid="B41-biomolecules-13-01191" ref-type="bibr">41</xref>]. Compounds <bold>38</bold>&#x02013;<bold>40</bold> could be produced by <italic toggle="yes">Pseudomonas aeruginosa</italic> to promote the growth of plant with auxin-like activity through the LasI QS system. The QS-regulated bacterial production of DKPs <bold>38</bold>&#x02013;<bold>40</bold> adjusts auxin signaling and plant growth promotion, which establishes a significant function for DKPs mediating trans-kingdom signaling between prokaryote and eukaryote [<xref rid="B63-biomolecules-13-01191" ref-type="bibr">63</xref>]. Compounds <bold>38</bold> and cyclo(L-Leu-L-Pro) showed synergistic antimicrobial activity against vancomycin-resistant enterococci (VRE) and pathogenic yeasts. The combination of <bold>38</bold> and cyclo(L-Leu-L-Pro) exhibited significant anti-VRE activity against <italic toggle="yes">Enterococcus faecium</italic> (K-99-38), <italic toggle="yes">E. faecalis</italic> (K-99-258), <italic toggle="yes">E. faecalis</italic> (K-99-17), <italic toggle="yes">E. faecalis</italic> (K-01-511), and <italic toggle="yes">E. faecium</italic> (K-01-312) with MIC values of 0.25&#x02013;1 &#x003bc;g/mL. It was also effective against <italic toggle="yes">E. coli</italic>, <italic toggle="yes">Micrococcus luteus</italic>, <italic toggle="yes">S. aureus</italic>, <italic toggle="yes">Cryptococcus neoformans,</italic> and <italic toggle="yes">C. albicans</italic> with MIC values of 0.25&#x02013;0.5 &#x003bc;g/mL. And the combination of <bold>38</bold> and cyclo(L-Leu-L-Pro) could reduce the mutation of strains <italic toggle="yes">Salmonella typhimurium</italic> TA98 and TA100 [<xref rid="B64-biomolecules-13-01191" ref-type="bibr">64</xref>,<xref rid="B65-biomolecules-13-01191" ref-type="bibr">65</xref>]. Compounds <bold>38</bold>&#x02013;<bold>40</bold> displayed antifungal activities against <italic toggle="yes">Ganoderma plantarum</italic> at the concentrations of 6.8, 8.2, and 8.2 mM, respectively, and <bold>38</bold> also showed anti-<italic toggle="yes">Candida</italic> activity at a concentration of 7.0 mM [<xref rid="B66-biomolecules-13-01191" ref-type="bibr">66</xref>]. Compounds <bold>38</bold> and <bold>39</bold> also demonstrated prominent activities against agriculturally important fungi, <italic toggle="yes">Pencillium expansum</italic>, <italic toggle="yes">Rhizoctonia solani</italic>, and <italic toggle="yes">Fusarium oxysporum</italic> with MIC values between 2 and 8 &#x000b5;g/mL, much higher than the commercial fungicide bavistin (MIC values was 50, 25 and 25 &#x000b5;g/mL, respectively) [<xref rid="B67-biomolecules-13-01191" ref-type="bibr">67</xref>]. Compound <bold>40</bold> showed antibacterial activity against MRSA 43300 with a zone of inhibition of 15 mm at a concentration of 20 &#x000b5;g/disc (the inhibition zone of the positive control gentamicin was 22 mm). And <bold>40</bold> had low toxicity against human hepatoma HepaRG cells, meaning it could be developed into a safe antibiotic [<xref rid="B68-biomolecules-13-01191" ref-type="bibr">68</xref>]. Compound <bold>38</bold> displayed weak cytotoxicity against HeLa, HT-29, and MCF-7 cell lines with IC<sub>50</sub> values of 2.92 &#x000b1; 1.55, 4.04 &#x000b1; 1.15, and 6.53 &#x000b1; 1.26 mM, and could induce apoptosis in HT-29 colon cancer cells [<xref rid="B69-biomolecules-13-01191" ref-type="bibr">69</xref>]. The cytotoxicity of <bold>38</bold> in HT-29 cells could be mediated by a caspase cascade [<xref rid="B70-biomolecules-13-01191" ref-type="bibr">70</xref>]. Furthermore, <bold>38</bold> also showed enzyme inhibition to topoisomerase I with an IC<sub>50</sub> value of 13 &#x000b5;M, stronger than the positive control cryptotanshinone with an IC<sub>50</sub> value of 17 &#x000b5;M [<xref rid="B71-biomolecules-13-01191" ref-type="bibr">71</xref>]. Compounds <bold>38</bold> and <bold>40</bold> exhibited anti-larval activities toward barnacle <italic toggle="yes">Balanus amphitrite</italic>, with effective concentrations inhibiting 50% larval attachment (EC<sub>50</sub>) after 24 h of 0.28 and 0.10 mM, respectively [<xref rid="B72-biomolecules-13-01191" ref-type="bibr">72</xref>,<xref rid="B73-biomolecules-13-01191" ref-type="bibr">73</xref>]. And <bold>38</bold> and <bold>40</bold> also showed antioxidant activities toward OH<sup>&#x02022;</sup> with an inhibition of 64.9% and 54.1% at 2.5 &#x000b5;M, respectively [<xref rid="B74-biomolecules-13-01191" ref-type="bibr">74</xref>]. Compound <bold>42</bold> exhibited weak cytotoxicity against ECA-109, Hela-S3, and PANC-1 cancer cells with the inhibition rates of 44%, 52%, and 55%, respectively, at 20 &#x000b5;M, and <bold>42</bold> could mildly increase the transcriptional activation of RXR&#x003b1; [<xref rid="B75-biomolecules-13-01191" ref-type="bibr">75</xref>]. Compound <bold>42</bold> exhibited anti-fouling activity against cyprid larvae of the barnacle with an LC<sub>50</sub> value of 3.5 &#x003bc;g/mL [<xref rid="B76-biomolecules-13-01191" ref-type="bibr">76</xref>]. Compound <bold>42</bold> could obviously increase the calcium ion concentration ([Ca<sup>2+</sup>]<sub>i</sub>) in myocytes, which is heavily dependent on the extracellular Ca<sup>2+</sup> influx [<xref rid="B77-biomolecules-13-01191" ref-type="bibr">77</xref>]. The LPS-induced migration, adhesion, and hyperpermeability of leukocytes to a human endothelial cell monolayer and in mice could be inhibited by <bold>42</bold> in a dose-dependent manner, suggesting that <bold>42</bold> may possess the potential to be developed into therapeutic agents to treat vascular inflammatory disorders [<xref rid="B78-biomolecules-13-01191" ref-type="bibr">78</xref>]. In addition, <bold>42</bold> was proved to suppress TGFBIp-mediated and CLP-induced septic responses, indicating that <bold>42</bold> could be a key candidate for therapy of the different vascular inflammatory diseases by repressing the TGFBIp signaling pathway [<xref rid="B79-biomolecules-13-01191" ref-type="bibr">79</xref>].</p></sec><sec id="sec4dot2-biomolecules-13-01191"><title>4.2. Pyranone Derivatives</title><p>One pyranone derivative, 3-methoxy-2-methyl-4<italic toggle="yes">H</italic>-pyran-4-one (<bold>43</bold>) (<xref rid="biomolecules-13-01191-f005" ref-type="fig">Figure 5</xref>), was isolated from the culture extract of the fungus <italic toggle="yes">A. luteoalbus</italic> SCSIO F457 [<xref rid="B41-biomolecules-13-01191" ref-type="bibr">41</xref>]. Compound <bold>43</bold> displayed no DPPH free radical scavenging or antibacterial activities [<xref rid="B41-biomolecules-13-01191" ref-type="bibr">41</xref>]. In addition, <bold>43</bold> exhibited antibacterial activity against <italic toggle="yes">S. aureus</italic> ATCC 25923, <italic toggle="yes">Enterococcus faecalis</italic> ATCC 29212 and <italic toggle="yes">E. faecium</italic> K59&#x02013;68 with MIC values of 25, 12.5, and 12.5 &#x000b5;g/mL, respectively [<xref rid="B80-biomolecules-13-01191" ref-type="bibr">80</xref>]. The study used bioactivity tracking and molecular networking to examine the secondary metabolites of the Antarctic soil-derived fungus <italic toggle="yes">A. luteoalbus</italic> CH-6, resulting in the discovery of two new &#x003b1;-pyrones, acrostalapyrones A (<bold>44</bold>) and B (<bold>45</bold>), along with one previously identified analog, multiforisin G (<bold>46</bold>) (<xref rid="biomolecules-13-01191-f005" ref-type="fig">Figure 5</xref>) [<xref rid="B9-biomolecules-13-01191" ref-type="bibr">9</xref>]. Compound <bold>46</bold> displayed significant immunosuppressive activity against LPS or Con A-(T-cells)-induced proliferations of mouse splenic lymphocytes (B-cells), with IC<sub>50</sub> values of 1.2 and 0.9 &#x000b5;g/mL, respectively, which was stronger than that of positive control azathioprine (IC<sub>50</sub> = 2.7 &#x000b5;g/mL) [<xref rid="B81-biomolecules-13-01191" ref-type="bibr">81</xref>].</p></sec><sec id="sec4dot3-biomolecules-13-01191"><title>4.3. Paulownin and Benzene Derivatives</title><p>One benzo-tetrahydrofuran-lignin, paulownin (<bold>47</bold>), and three benzene derivatives, 1-methyoxy-4-(2-hydroxy)ethylbenzene (<bold>48</bold>), 2-(4-hydroxyphenyl)-ethanol (<bold>49</bold>), and 1-phenylbutane-2,3-diol (<bold>50</bold>) (<xref rid="biomolecules-13-01191-f005" ref-type="fig">Figure 5</xref>), were isolated from the deep-sea sediment-derived fungus <italic toggle="yes">A. luteoalbus</italic> SCSIO F457, using the OSMAC strategy [<xref rid="B41-biomolecules-13-01191" ref-type="bibr">41</xref>]. The absolute configuration of <bold>50</bold> was not confirmed. Compound <bold>48</bold> showed antioxidant activity, and the IC<sub>50</sub> of DPPH free radical scavenging of <bold>48</bold> was 240.05 &#x003bc;g/mL [<xref rid="B41-biomolecules-13-01191" ref-type="bibr">41</xref>].</p></sec></sec><sec sec-type="conclusions" id="sec5-biomolecules-13-01191"><title>5. Conclusions</title><p>Between 1969 and 2022, researchers isolated 50 natural products from the genus <italic toggle="yes">Acrostalagmus</italic>, and 50% of these compounds are newly discovered. Between 1975 and 2011, there was a lack of research on the secondary metabolites of the genus <italic toggle="yes">Acrostalagmus</italic>, with only nine compounds isolated before 1974. However, the compounds from this genus started to attract the attention of researchers after 2012. Interestingly, all the compounds isolated between 2012 and 2022 are derived from the marine <italic toggle="yes">Acrostalagmus</italic>, and they comprise 82% of the natural products discovered from this genus (<xref rid="biomolecules-13-01191-t001" ref-type="table">Table 1</xref>). Thess findings highlight the ocean as a vast resource treasury and suggest that the marine-derived genus <italic toggle="yes">Acrostalagmus</italic> possesses the ability to produce abundant secondary metabolites.</p><p>The compounds isolated from the genus <italic toggle="yes">Acrostalagmus</italic> exhibit diverse structures, including terpenoids, alkaloids, peptides, pyranones, benzene derivatives, and paulownin. Among these compounds, alkaloids are of particular importance, comprising 56% of the natural products derived from this genus (<xref rid="biomolecules-13-01191-f006" ref-type="fig">Figure 6</xref>). Furthermore, within the alkaloid class, 61% belong to the epipolythiodioxopiperazine family. This substantial proportion highlights the significance of epipolythiodioxopiperazine as a key characteristic structure within the genus <italic toggle="yes">Acrostalagmus</italic>.</p><p>The genus <italic toggle="yes">Acrostalagmus</italic> has the potential to produce a variety of secondary metabolites with diverse bioactivities, including plant growth regulation, enzyme, Hsp90, and biofilm inhibitions, cytotoxic, antimicrobial, nematicidal, anti-inflammatory, immunosuppressive, antifouling, anti-QS, brine shrimp lethal, and antioxidant activities (<xref rid="biomolecules-13-01191-f007" ref-type="fig">Figure 7</xref>). Research indicates that 72% of the natural products obtained from <italic toggle="yes">Acrostalagmus</italic> exhibit bioactive activities, with compounds <bold>1</bold>, <bold>10</bold>, <bold>12</bold>, <bold>13</bold>, <bold>15</bold>, <bold>32</bold>, <bold>35</bold>, <bold>36</bold>, <bold>38</bold>, <bold>40</bold>, and <bold>42</bold> displaying more than three types of activity, and 50% of the bioactive compounds exhibiting prominent activities comparable or stronger than their positive controls, which further demonstrates the potential ability of this genus to produce bioactive natural products (<xref rid="biomolecules-13-01191-f007" ref-type="fig">Figure 7</xref>). </p><p>The bioactive compounds isolated from the genus <italic toggle="yes">Acrostalagmus</italic> mainly focus on cytotoxic (19%), enzyme inhibitory (17%), and antimicrobial (29%, with antibacterial (17%) and antifungal (12%) activities) activities (<xref rid="biomolecules-13-01191-f008" ref-type="fig">Figure 8</xref>), indicating considerable potential for the development of new anticancer compounds, enzyme inhibitors, and antibiotics from <italic toggle="yes">Acrostalagmus</italic>.</p><p>According to research, 72% of natural products derived from <italic toggle="yes">Acrostalagmus</italic> display bioactivities, with 50% of the bioactive compounds exhibiting more significant or comparable activities than their positive controls (<xref rid="biomolecules-13-01191-t002" ref-type="table">Table 2</xref>, <xref rid="biomolecules-13-01191-t003" ref-type="table">Table 3</xref> and <xref rid="biomolecules-13-01191-t004" ref-type="table">Table 4</xref>). Most of the compounds with remarkable activities (67%) belong to the family of epipolythiodioxopiperazine, confirming the potential of this structure as a precursor for the development of novel drugs. Eighty-nine percent of potent active compounds are isolated from marine derived fungi, further demonstrating the development potential of marine fungi.</p><p>The stronger cytotoxic activities of compounds <bold>3</bold> and <bold>10</bold>&#x02013;<bold>17</bold> compared to their positive control (<xref rid="biomolecules-13-01191-f007" ref-type="fig">Figure 7</xref>, <xref rid="biomolecules-13-01191-t002" ref-type="table">Table 2</xref>) support their potential as new anticancer drugs. Compounds <bold>9</bold>, <bold>12</bold>, <bold>31,</bold> and <bold>32</bold> exhibit more significant antibacterial activities than their positive controls, and <bold>16</bold> and <bold>30</bold> show comparable antibacterial activities compared to their positive control (<xref rid="biomolecules-13-01191-f007" ref-type="fig">Figure 7</xref>, <xref rid="biomolecules-13-01191-t003" ref-type="table">Table 3</xref>), meaning they could be valuable starting points for the development of new antibiotics. Notably, compounds <bold>9</bold>, <bold>12,</bold> and <bold>32</bold> demonstrate stronger antibacterial activities against MRSA than their positive controls (<xref rid="biomolecules-13-01191-f007" ref-type="fig">Figure 7</xref>, <xref rid="biomolecules-13-01191-t003" ref-type="table">Table 3</xref>), addressing the challenge of bacterial drug resistance. The combination of <bold>38</bold> and cyclo(L-Leu-L-Pro) exhibited obvious synergistic effect, with significant antimicrobial activity against VRE and pathogenic yeasts, which supports their potential use as synergistic antibiotics. Compounds <bold>38</bold> and <bold>39</bold> demonstrate prominent activities against agriculturally important fungi, much higher than the commercial fungicide bavistin, declaring the potential of <bold>38</bold> and <bold>39</bold> to be applied in agricultural fungicide (<xref rid="biomolecules-13-01191-f007" ref-type="fig">Figure 7</xref>, <xref rid="biomolecules-13-01191-t003" ref-type="table">Table 3</xref>). </p><p>Compound <bold>1</bold> exhibits greater inhibition of germination and growth development at a concentration of 10<sup>&#x02212;4</sup> M compared to the commercial herbicide LOGRAN<sup>&#x000ae;</sup>. This indicates the potential for developing compound <bold>1</bold> as a new herbicide (<xref rid="biomolecules-13-01191-f007" ref-type="fig">Figure 7</xref>, <xref rid="biomolecules-13-01191-t004" ref-type="table">Table 4</xref>). Compound <bold>15</bold> displays more potent inhibition of mushroom tyrosinase compared to the positive control kojic acid (<xref rid="biomolecules-13-01191-f007" ref-type="fig">Figure 7</xref>, <xref rid="biomolecules-13-01191-t004" ref-type="table">Table 4</xref>), which demonstrates that <bold>1</bold> could be employed in various fields such as whitening and health care, treatment of pigmented skin diseases, pest control, and food preservation. Compound <bold>35</bold> exhibits stronger inhibition of the biofilm formation in <italic toggle="yes">P. aeruginosa</italic> PA01 than the positive control AZM, indicating <bold>35</bold> can serve as leading compound in developing new antimicrobial drugs for clinical or agricultural research. Compound <bold>35</bold> also shows more significant enzyme inhibition against <italic toggle="yes">&#x003b1;</italic>-glucosidase (AGS) than the positive control acarbose. In addition, <bold>35</bold> shows no cytotoxicity to the human normal hepatocyte (LO2) cells, suggesting the safety of <bold>35</bold> to be developed into hypoglycemic agent (<xref rid="biomolecules-13-01191-f007" ref-type="fig">Figure 7</xref>, <xref rid="biomolecules-13-01191-t004" ref-type="table">Table 4</xref>). Compound <bold>38</bold> displays potent enzyme inhibition to topoisomerase I, stronger than the positive control cryptotanshinone, suggesting it can be developed into new antitumor drugs (<xref rid="biomolecules-13-01191-f007" ref-type="fig">Figure 7</xref>, <xref rid="biomolecules-13-01191-t004" ref-type="table">Table 4</xref>). Compound <bold>46</bold> displays significant immunosuppressive activity, stronger than that of positive control azathioprine, which has the potential to be developed into immunomodulatory drugs (<xref rid="biomolecules-13-01191-f007" ref-type="fig">Figure 7</xref>, <xref rid="biomolecules-13-01191-t004" ref-type="table">Table 4</xref>). These results further suggest that the genus <italic toggle="yes">Acrostalagmus</italic> holds promise as a source of bioactive compounds.</p><p>In this review, we comprehensively summarized the chemical structure types, biosynthesis, bioactivity, sources, and distribution of the secondary metabolites isolated from <italic toggle="yes">Acrostalagmus</italic> in the period between 1969 and 2022. The literature survey indicates that <italic toggle="yes">Acrostalagmus</italic>, especially marine derived <italic toggle="yes">Acrostalagmus</italic>, has great potential to produce abundant and diverse new bioactive natural products, and the family of epipolythiodioxopiperazine, with its significant bioactivities, could be one of the characteristic compound groups of the genus <italic toggle="yes">Acrostalagmus</italic>.</p></sec></body><back><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes><title>Author Contributions</title><p>T.S. collected the literature regarding natural products isolated from <italic toggle="yes">Acrostalagmus</italic>, and wrote the paper; H.W., Y.-J.L., Y.-F.W., and Q.P. revised the manuscript; B.W. and E.-L.S. organized and guided the writing of the manuscript. All authors have read and agreed to the published version of the manuscript.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-biomolecules-13-01191"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>He</surname><given-names>S.</given-names></name>
<name><surname>Jin</surname><given-names>X.</given-names></name>
<name><surname>Wang</surname><given-names>S.</given-names></name>
</person-group><article-title>Antagonistic activity of <italic toggle="yes">Acrostalagmus luteo-albus</italic> against plant pathogenic fungi</article-title><source>J. Gansu Agric. Univ.</source><year>2010</year><volume>45</volume><fpage>60</fpage><lpage>65</lpage></element-citation></ref><ref id="B2-biomolecules-13-01191"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bondarenko</surname><given-names>S.A.</given-names></name>
<name><surname>Georgieva</surname><given-names>M.L.</given-names></name>
<name><surname>Bilanenko</surname><given-names>E.N.</given-names></name>
</person-group><article-title>Alkalitolerant micromycetes in acidic and neutral soils of the temperate zone</article-title><source>Microbiology</source><year>2016</year><volume>85</volume><fpage>737</fpage><lpage>744</lpage><pub-id pub-id-type="doi">10.1134/S0026261716060035</pub-id></element-citation></ref><ref id="B3-biomolecules-13-01191"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bondarenko</surname><given-names>S.A.</given-names></name>
<name><surname>Ianutsevich</surname><given-names>E.A.</given-names></name>
<name><surname>Sinitsyna</surname><given-names>N.A.</given-names></name>
<name><surname>Georgieva</surname><given-names>M.L.</given-names></name>
<name><surname>Bilanenko</surname><given-names>E.N.</given-names></name>
<name><surname>Tereshina</surname><given-names>B.M.</given-names></name>
</person-group><article-title>Dynamics of the cytosol soluble carbohydrates and membrane lipids in response to ambient pH in alkaliphilic and alkalitolerant fungi</article-title><source>Microbiology</source><year>2018</year><volume>87</volume><fpage>21</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1134/S0026261718010034</pub-id></element-citation></ref><ref id="B4-biomolecules-13-01191"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rojas</surname><given-names>N.L.</given-names></name>
<name><surname>Cavalitto</surname><given-names>S.F.</given-names></name>
<name><surname>Cabello</surname><given-names>M.</given-names></name>
<name><surname>Hours</surname><given-names>R.A.</given-names></name>
<name><surname>Voget</surname><given-names>C.E.</given-names></name>
</person-group><article-title>Alkaline polysaccharidases produced in solid state cultures by alkalophilic fungi isolated from Argentina</article-title><source>J. Pure Appl. Microbiol.</source><year>2008</year><volume>2</volume><fpage>1</fpage><lpage>10</lpage></element-citation></ref><ref id="B5-biomolecules-13-01191"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kavitha</surname><given-names>P.G.</given-names></name>
<name><surname>Sudha</surname><given-names>A.</given-names></name>
<name><surname>Devi</surname><given-names>P.A.</given-names></name>
<name><surname>Kumaran</surname><given-names>K.</given-names></name>
</person-group><article-title>A comparative study on forest soil microbial diversity and biomass in nilgiri biosphere of Southern India</article-title><source>Int. J. Curr. Microbiol. Appl. Sci.</source><year>2020</year><volume>9</volume><fpage>3701</fpage><lpage>3715</lpage><pub-id pub-id-type="doi">10.20546/ijcmas.2020.909.457</pub-id></element-citation></ref><ref id="B6-biomolecules-13-01191"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Monoson</surname><given-names>H.L.</given-names></name>
<name><surname>Conway</surname><given-names>T.D.</given-names></name>
<name><surname>Nelson</surname><given-names>R.E.</given-names></name>
</person-group><article-title>Four endoparasitic nematode destroying fungi isolated from sand ridge state forest soil</article-title><source>Mycopathologia</source><year>1975</year><volume>57</volume><fpage>59</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1007/BF00431181</pub-id><pub-id pub-id-type="pmid">1239663</pub-id></element-citation></ref><ref id="B7-biomolecules-13-01191"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nguyen</surname><given-names>M.T.H.D.</given-names></name>
<name><surname>Thomas</surname><given-names>T.</given-names></name>
</person-group><article-title>Diversity, host-specificity and stability of sponge-associated fungal communities of co-occurring sponges</article-title><source>PeerJ</source><year>2018</year><volume>6</volume><fpage>e4965</fpage><pub-id pub-id-type="doi">10.7717/peerj.4965</pub-id><?supplied-pmid 29888140?><pub-id pub-id-type="pmid">29888140</pub-id></element-citation></ref><ref id="B8-biomolecules-13-01191"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Youssef</surname><given-names>F.S.</given-names></name>
<name><surname>Simal-Gandara</surname><given-names>J.</given-names></name>
</person-group><article-title>Comprehensive overview on the chemistry and biological activities of selected alkaloid producing marine-derived fungi as a valuable reservoir of drug entities</article-title><source>Biomedicines</source><year>2021</year><volume>9</volume><elocation-id>485</elocation-id><pub-id pub-id-type="doi">10.3390/biomedicines9050485</pub-id><pub-id pub-id-type="pmid">33925060</pub-id></element-citation></ref><ref id="B9-biomolecules-13-01191"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shi</surname><given-names>T.</given-names></name>
<name><surname>Li</surname><given-names>X.-Q.</given-names></name>
<name><surname>Wang</surname><given-names>Z.-M.</given-names></name>
<name><surname>Yu</surname><given-names>Y.-Y.</given-names></name>
<name><surname>Dai</surname><given-names>J.-J.</given-names></name>
<name><surname>Shi</surname><given-names>D.-Y.</given-names></name>
<name><surname>Zheng</surname><given-names>L.</given-names></name>
</person-group><article-title>Bioactivity-guided screening of antimicrobial secondary metabolites from Antarctic cultivable fungus <italic toggle="yes">Acrostalagmus luteoalbus</italic> CH-6 combined with molecular networking</article-title><source>Mar. Drugs</source><year>2022</year><volume>20</volume><elocation-id>334</elocation-id><pub-id pub-id-type="doi">10.3390/md20050334</pub-id><pub-id pub-id-type="pmid">35621985</pub-id></element-citation></ref><ref id="B10-biomolecules-13-01191"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Amatayakul</surname><given-names>T.</given-names></name>
</person-group><article-title>Synthesis of fibrinolysin by fungi</article-title><source>Ohio J. Sci.</source><year>1955</year><volume>55</volume><fpage>343</fpage><lpage>353</lpage></element-citation></ref><ref id="B11-biomolecules-13-01191"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Artigues</surname><given-names>M.</given-names></name>
<name><surname>Davet</surname><given-names>P.</given-names></name>
</person-group><article-title>&#x003b2;-(1 &#x02192; 3)-glucanase and chitinase activities in some fungi in relation to their antisclerotic activity towards <italic toggle="yes">Corticium rolfsii</italic> in sterile soil</article-title><source>Soil Biol. Biochem.</source><year>1984</year><volume>16</volume><fpage>527</fpage><lpage>528</lpage><pub-id pub-id-type="doi">10.1016/0038-0717(84)90064-6</pub-id></element-citation></ref><ref id="B12-biomolecules-13-01191"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rojas</surname><given-names>N.L.</given-names></name>
<name><surname>Voget</surname><given-names>C.E.</given-names></name>
<name><surname>Hours</surname><given-names>R.A.</given-names></name>
<name><surname>Cavalitto</surname><given-names>S.F.</given-names></name>
</person-group><article-title>Purification and characterization of a novel alkaline &#x003b1;-<italic toggle="yes">L</italic>-rhamnosidase produced by <italic toggle="yes">Acrostalagmus luteoalbus</italic></article-title><source>J. Ind. Microbiol. Biotechnol.</source><year>2011</year><volume>38</volume><fpage>1515</fpage><lpage>1522</lpage><pub-id pub-id-type="doi">10.1007/s10295-010-0938-8</pub-id><pub-id pub-id-type="pmid">21221705</pub-id></element-citation></ref><ref id="B13-biomolecules-13-01191"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Soprunov</surname><given-names>F.F.</given-names></name>
<name><surname>Galiulina</surname><given-names>Z.A.</given-names></name>
</person-group><article-title>Predatory hyphomycetes from Turkmenistan soils</article-title><source>Mikrobiologiya</source><year>1951</year><volume>20</volume><fpage>489</fpage><lpage>499</lpage><pub-id pub-id-type="pmid">14899376</pub-id></element-citation></ref><ref id="B14-biomolecules-13-01191"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jackson</surname><given-names>R.M.</given-names></name>
</person-group><article-title>Some aspects of soil fungistasis</article-title><source>J. Gen. Microbiol.</source><year>1958</year><volume>19</volume><fpage>390</fpage><lpage>401</lpage><pub-id pub-id-type="doi">10.1099/00221287-19-2-390</pub-id><pub-id pub-id-type="pmid">13587904</pub-id></element-citation></ref><ref id="B15-biomolecules-13-01191"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jensen</surname><given-names>H.L.</given-names></name>
</person-group><article-title>Carbon nutrition of some microorganisms decomposing halogen-substituted aliphatic acids</article-title><source>Acta Agric. Scand.</source><year>1963</year><volume>13</volume><fpage>404</fpage><lpage>412</lpage><pub-id pub-id-type="doi">10.1080/00015126309435665</pub-id></element-citation></ref><ref id="B16-biomolecules-13-01191"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Huang</surname><given-names>Z.</given-names></name>
<name><surname>Wang</surname><given-names>F.</given-names></name>
<name><surname>Tian</surname><given-names>X.</given-names></name>
<name><surname>Li</surname><given-names>J.</given-names></name>
<name><surname>Zhang</surname><given-names>S.</given-names></name>
</person-group><article-title>Identification and activities of fungal strain 00457 isolated from the deep-sea sediment of northern south china sea</article-title><source>Shengwu Jishu Tongbao</source><year>2012</year><volume>10</volume><fpage>199</fpage><lpage>204</lpage></element-citation></ref><ref id="B17-biomolecules-13-01191"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Khalmuratovalt</surname><given-names>I.</given-names></name>
<name><surname>Choilt</surname><given-names>D.-H.</given-names></name>
<name><surname>Yoon</surname><given-names>H.-J.</given-names></name>
<name><surname>Yoon</surname><given-names>T.-W.</given-names></name>
<name><surname>Kim</surname><given-names>J.-G.</given-names></name>
</person-group><article-title>Diversity and plant growth promotion of fungal endophytes in five halophytes from the buan salt marsh</article-title><source>J. Microbiol. Biotechnol.</source><year>2021</year><volume>31</volume><fpage>408</fpage><lpage>418</lpage><pub-id pub-id-type="doi">10.4014/jmb.2012.12041</pub-id><?supplied-pmid 33397833?><pub-id pub-id-type="pmid">33397833</pub-id></element-citation></ref><ref id="B18-biomolecules-13-01191"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Andersson</surname><given-names>A.M.A.</given-names></name>
<name><surname>Salo</surname><given-names>J.</given-names></name>
<name><surname>Mikkola</surname><given-names>R.</given-names></name>
<name><surname>Kurnitski</surname><given-names>J.</given-names></name>
<name><surname>Salonen</surname><given-names>H.</given-names></name>
<name><surname>Marik</surname><given-names>T.</given-names></name>
<name><surname>Kredics</surname><given-names>L.</given-names></name>
</person-group><article-title>Melinacidin-producing <italic toggle="yes">Acrostalagmus luteoalbus</italic>, a major constituent of mixed mycobiota contaminating insulation material in an outdoor wall</article-title><source>Pathogens</source><year>2021</year><volume>10</volume><elocation-id>843</elocation-id><pub-id pub-id-type="doi">10.3390/pathogens10070843</pub-id><pub-id pub-id-type="pmid">34357993</pub-id></element-citation></ref><ref id="B19-biomolecules-13-01191"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ellestad</surname><given-names>G.A.</given-names></name>
<name><surname>Evans</surname><given-names>R.H.</given-names><suffix>Jr.</suffix></name>
<name><surname>Kunstmann</surname><given-names>M.P.</given-names></name>
</person-group><article-title>Structure of a C<sup>17</sup> antifungal terpenoid from an unidentified <italic toggle="yes">Acrostalagmus</italic> species</article-title><source>J. Am. Chem. Soc.</source><year>1969</year><volume>91</volume><fpage>2134</fpage><lpage>2136</lpage><pub-id pub-id-type="doi">10.1021/ja01036a060</pub-id><pub-id pub-id-type="pmid">5816182</pub-id></element-citation></ref><ref id="B20-biomolecules-13-01191"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ellestad</surname><given-names>G.A.</given-names></name>
<name><surname>Evans</surname><given-names>R.H.</given-names><suffix>Jr.</suffix></name>
<name><surname>Kunstmann</surname><given-names>M.P.</given-names></name>
<name><surname>Lancaster</surname><given-names>J.E.</given-names></name>
<name><surname>Morton</surname><given-names>G.O.</given-names></name>
</person-group><article-title>Structure and chemistry of antibiotic LL-Z1271&#x003b1;, an antifungal carbon-17 terpene</article-title><source>J. Am. Chem. Soc.</source><year>1970</year><volume>92</volume><fpage>5483</fpage><lpage>5489</lpage><pub-id pub-id-type="doi">10.1021/ja00721a031</pub-id><?supplied-pmid 5465204?><pub-id pub-id-type="pmid">5465204</pub-id></element-citation></ref><ref id="B21-biomolecules-13-01191"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ellestad</surname><given-names>G.A.</given-names></name>
<name><surname>Evans</surname><given-names>R.H.</given-names><suffix>Jr.</suffix></name>
<name><surname>Kunstmann</surname><given-names>M.P.</given-names></name>
</person-group><article-title>LL-Z1271&#x003b2; [C<sub>16</sub>H<sub>24</sub>O<sub>5</sub>], an additional C<sup>16</sup> terpenoid metabolite from an <italic toggle="yes">Acrostalagmus</italic> species</article-title><source>Tetrahedron Lett.</source><year>1971</year><volume>12</volume><fpage>497</fpage><lpage>500</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(01)96479-2</pub-id></element-citation></ref><ref id="B22-biomolecules-13-01191"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sato</surname><given-names>M.</given-names></name>
<name><surname>Ruo</surname><given-names>T.-I.</given-names></name>
<name><surname>Hayashi</surname><given-names>T.</given-names></name>
<name><surname>Kakisawa</surname><given-names>H.</given-names></name>
<name><surname>Miyaki</surname><given-names>T.</given-names></name>
<name><surname>Yamamoto</surname><given-names>H.</given-names></name>
<name><surname>Fujisawa</surname><given-names>K.</given-names></name>
</person-group><article-title>Structure of C<sup>16</sup>-terpenes from <italic toggle="yes">Acrostalagmus</italic></article-title><source>Tetrahedron Lett.</source><year>1974</year><volume>15</volume><fpage>2183</fpage><lpage>2186</lpage><pub-id pub-id-type="doi">10.1016/S0040-4039(01)93171-5</pub-id></element-citation></ref><ref id="B23-biomolecules-13-01191"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rusman</surname><given-names>Y.</given-names></name>
<name><surname>Wilson</surname><given-names>M.B.</given-names></name>
<name><surname>Williams</surname><given-names>J.M.</given-names></name>
<name><surname>Held</surname><given-names>B.W.</given-names></name>
<name><surname>Blanchette</surname><given-names>R.A.</given-names></name>
<name><surname>Anderson</surname><given-names>B.N.</given-names></name>
<name><surname>Lupfer</surname><given-names>C.R.</given-names></name>
<name><surname>Salomon</surname><given-names>C.E.</given-names></name>
</person-group><article-title>Antifungal norditerpene oidiolactones from the fungus <italic toggle="yes">Oidiodendron truncatum</italic>, a potential biocontrol agent for White-Nose Syndrome in bats</article-title><source>J. Nat. Prod.</source><year>2020</year><volume>83</volume><fpage>344</fpage><lpage>353</lpage><pub-id pub-id-type="doi">10.1021/acs.jnatprod.9b00789</pub-id><pub-id pub-id-type="pmid">31986046</pub-id></element-citation></ref><ref id="B24-biomolecules-13-01191"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pettit</surname><given-names>G.R.</given-names></name>
<name><surname>Tan</surname><given-names>R.</given-names></name>
<name><surname>Herald</surname><given-names>D.L.</given-names></name>
<name><surname>Hamblin</surname><given-names>J.</given-names></name>
<name><surname>Pettit</surname><given-names>R.K.</given-names></name>
</person-group><article-title>Antineoplastic agents. 488. isolation and structure of Yukonin from a yukon territory fungus</article-title><source>J. Nat. Prod.</source><year>2003</year><volume>66</volume><fpage>276</fpage><lpage>278</lpage><pub-id pub-id-type="doi">10.1021/np020144m</pub-id><pub-id pub-id-type="pmid">12608865</pub-id></element-citation></ref><ref id="B25-biomolecules-13-01191"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Deng</surname><given-names>C.</given-names></name>
<name><surname>Huang</surname><given-names>C.</given-names></name>
<name><surname>Wu</surname><given-names>Q.</given-names></name>
<name><surname>Pang</surname><given-names>J.</given-names></name>
<name><surname>Lin</surname><given-names>Y.</given-names></name>
</person-group><article-title>A new sesquiterpene from the mangrove endophytic fungus <italic toggle="yes">Aspergillus terreus</italic> (No. GX7-3B)</article-title><source>Nat. Prod. Res.</source><year>2013</year><volume>27</volume><fpage>1882</fpage><lpage>1887</lpage><pub-id pub-id-type="doi">10.1080/14786419.2013.778847</pub-id><pub-id pub-id-type="pmid">23521163</pub-id></element-citation></ref><ref id="B26-biomolecules-13-01191"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kakisawa</surname><given-names>H.</given-names></name>
<name><surname>Sato</surname><given-names>M.</given-names></name>
<name><surname>Ruo</surname><given-names>T.-i.</given-names></name>
<name><surname>Hayashi</surname><given-names>T.</given-names></name>
</person-group><article-title>Biosynthesis of a C<sup>16</sup>-terpenoid lactone, a plant growth regulator</article-title><source>J. Chem. Soc. Chem. Commun.</source><year>1973</year><volume>20</volume><fpage>802</fpage><lpage>803</lpage><pub-id pub-id-type="doi">10.1039/c39730000802</pub-id></element-citation></ref><ref id="B27-biomolecules-13-01191"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Barrero</surname><given-names>A.F.</given-names></name>
<name><surname>S&#x000e1;nchez</surname><given-names>J.F.</given-names></name>
<name><surname>Elmerabet</surname><given-names>J.</given-names></name>
<name><surname>Jim&#x000e9;nez-Gonz&#x000e1;lez</surname><given-names>D.</given-names></name>
<name><surname>Mac&#x000ed;as</surname><given-names>F.A.</given-names></name>
<name><surname>Simonet</surname><given-names>A.M.</given-names></name>
</person-group><article-title>Enantiospecific syntheses of the potent bioactives nagilactone F and the mould metabolite LL-Z1271&#x003b1; an evaluation of their allelopathic potential</article-title><source>Tetrahedron</source><year>1999</year><volume>55</volume><fpage>7289</fpage><lpage>7304</lpage><pub-id pub-id-type="doi">10.1016/S0040-4020(99)00355-5</pub-id></element-citation></ref><ref id="B28-biomolecules-13-01191"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dinarello</surname><given-names>C.A.</given-names></name>
</person-group><article-title>Inflammatory cytokines: Interleukin-1 and tumor necrosis factor as effector molecules in autoimmune diseases</article-title><source>Curr. Opin. Immunol.</source><year>1991</year><volume>3</volume><fpage>941</fpage><lpage>948</lpage><pub-id pub-id-type="doi">10.1016/S0952-7915(05)80018-4</pub-id><pub-id pub-id-type="pmid">1665333</pub-id></element-citation></ref><ref id="B29-biomolecules-13-01191"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ichikawa</surname><given-names>K.</given-names></name>
<name><surname>Inagaki</surname><given-names>T.</given-names></name>
<name><surname>Kachi-Tonai</surname><given-names>H.</given-names></name>
<name><surname>Kojima</surname><given-names>Y.</given-names></name>
<name><surname>Nakamura</surname><given-names>T.-a.</given-names></name>
<name><surname>Nishida</surname><given-names>H.</given-names></name>
<name><surname>Ueno</surname><given-names>Y.</given-names></name>
<name><surname>Binding</surname><given-names>P.</given-names></name>
<name><surname>Gabel</surname><given-names>C.A.</given-names></name>
<name><surname>Lucas</surname><given-names>V.</given-names></name>
</person-group><article-title>LL-Z1271&#x003b1;: An interleukin-1&#x003b2; production inhibitor</article-title><source>Biochem. Biophys. Res. Commun.</source><year>2001</year><volume>286</volume><fpage>697</fpage><lpage>700</lpage><pub-id pub-id-type="doi">10.1006/bbrc.2001.5458</pub-id><pub-id pub-id-type="pmid">11520053</pub-id></element-citation></ref><ref id="B30-biomolecules-13-01191"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ichikawa</surname><given-names>K.</given-names></name>
<name><surname>Hirai</surname><given-names>H.</given-names></name>
<name><surname>Ishiguro</surname><given-names>M.</given-names></name>
<name><surname>Kambara</surname><given-names>T.</given-names></name>
<name><surname>Kato</surname><given-names>Y.</given-names></name>
<name><surname>Kim</surname><given-names>Y.J.</given-names></name>
<name><surname>Kojima</surname><given-names>Y.</given-names></name>
<name><surname>Matsunaga</surname><given-names>Y.</given-names></name>
<name><surname>Nishida</surname><given-names>H.</given-names></name>
<name><surname>Shiomi</surname><given-names>Y.</given-names></name>
</person-group><article-title>Cytokine production inhibitors produced by a fungus, <italic toggle="yes">Oidiodendron griseum</italic></article-title><source>J. Antibiot.</source><year>2001</year><volume>54</volume><fpage>697</fpage><lpage>702</lpage><pub-id pub-id-type="doi">10.7164/antibiotics.54.697</pub-id></element-citation></ref><ref id="B31-biomolecules-13-01191"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Argoudelis</surname><given-names>A.D.</given-names></name>
<name><surname>Reusser</surname><given-names>F.</given-names></name>
</person-group><article-title>Melinacidins, a new family of antibiotics</article-title><source>J. Antibiot.</source><year>1971</year><volume>24</volume><fpage>383</fpage><pub-id pub-id-type="doi">10.7164/antibiotics.24.383</pub-id></element-citation></ref><ref id="B32-biomolecules-13-01191"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Reusser</surname><given-names>F.</given-names></name>
</person-group><article-title>Mode of action of melinacidin, an inhibitor of nicotinic acid biosynthesis</article-title><source>J. Bacteriol.</source><year>1968</year><volume>96</volume><fpage>1285</fpage><pub-id pub-id-type="doi">10.1128/jb.96.4.1285-1290.1968</pub-id><pub-id pub-id-type="pmid">4234838</pub-id></element-citation></ref><ref id="B33-biomolecules-13-01191"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Argoudelis</surname><given-names>A.D.</given-names></name>
</person-group><article-title>Melinacidins II, III, and IV. New 3,6-epidithiadiketopiperazine antibiotics</article-title><source>J. Antibiot.</source><year>1972</year><volume>25</volume><fpage>171</fpage><pub-id pub-id-type="doi">10.7164/antibiotics.25.171</pub-id></element-citation></ref><ref id="B34-biomolecules-13-01191"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Argoudelis</surname><given-names>A.D.</given-names></name>
<name><surname>Mizsak</surname><given-names>S.A.</given-names></name>
</person-group><article-title>Melinacidins II, III and IV structural studies</article-title><source>J. Antibiot.</source><year>1977</year><volume>30</volume><fpage>468</fpage><pub-id pub-id-type="doi">10.7164/antibiotics.30.468</pub-id><?supplied-pmid 885807?><pub-id pub-id-type="pmid">885807</pub-id></element-citation></ref><ref id="B35-biomolecules-13-01191"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Feng</surname><given-names>Y.</given-names></name>
<name><surname>Blunt</surname><given-names>J.W.</given-names></name>
<name><surname>Cole</surname><given-names>A.L.J.</given-names></name>
<name><surname>Cannon</surname><given-names>J.F.</given-names></name>
<name><surname>Robinson</surname><given-names>W.T.</given-names></name>
<name><surname>Munro</surname><given-names>M.H.G.</given-names></name>
</person-group><article-title>Two novel cytotoxic cyclodepsipeptides from a mycoparasitic <italic toggle="yes">Cladobotryum</italic> sp.</article-title><source>J. Org. Chem.</source><year>2003</year><volume>68</volume><fpage>2002</fpage><lpage>2005</lpage><pub-id pub-id-type="doi">10.1021/jo0263059</pub-id><?supplied-pmid 12608823?><pub-id pub-id-type="pmid">12608823</pub-id></element-citation></ref><ref id="B36-biomolecules-13-01191"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ebead</surname><given-names>G.A.</given-names></name>
<name><surname>Overy</surname><given-names>D.P.</given-names></name>
<name><surname>Berru&#x000e9;</surname><given-names>F.</given-names></name>
<name><surname>Kerr</surname><given-names>R.G.</given-names></name>
</person-group><article-title><italic toggle="yes">Westerdykella reniformis</italic> sp. nov., producing the antibiotic metabolites melinacidin IV and chetracin B</article-title><source>IMA Fungus</source><year>2012</year><volume>3</volume><fpage>189</fpage><lpage>201</lpage><pub-id pub-id-type="doi">10.5598/imafungus.2012.03.02.11</pub-id><pub-id pub-id-type="pmid">23355972</pub-id></element-citation></ref><ref id="B37-biomolecules-13-01191"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>F.-Z.</given-names></name>
<name><surname>Huang</surname><given-names>Z.</given-names></name>
<name><surname>Shi</surname><given-names>X.-F.</given-names></name>
<name><surname>Chen</surname><given-names>Y.-C.</given-names></name>
<name><surname>Zhang</surname><given-names>W.-M.</given-names></name>
<name><surname>Tian</surname><given-names>X.-P.</given-names></name>
<name><surname>Li</surname><given-names>J.</given-names></name>
<name><surname>Zhang</surname><given-names>S.</given-names></name>
</person-group><article-title>Cytotoxic indole diketopiperazines from the deep sea-derived fungus <italic toggle="yes">Acrostalagmus luteoalbus</italic> SCSIO F457</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2012</year><volume>22</volume><fpage>7265</fpage><lpage>7267</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2012.08.115</pub-id><?supplied-pmid 23079524?><pub-id pub-id-type="pmid">23079524</pub-id></element-citation></ref><ref id="B38-biomolecules-13-01191"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yu</surname><given-names>G.</given-names></name>
<name><surname>Wang</surname><given-names>Y.</given-names></name>
<name><surname>Yu</surname><given-names>R.</given-names></name>
<name><surname>Feng</surname><given-names>Y.</given-names></name>
<name><surname>Wang</surname><given-names>L.</given-names></name>
<name><surname>Che</surname><given-names>Q.</given-names></name>
<name><surname>Gu</surname><given-names>Q.</given-names></name>
<name><surname>Li</surname><given-names>D.</given-names></name>
<name><surname>Li</surname><given-names>J.</given-names></name>
<name><surname>Zhu</surname><given-names>T.</given-names></name>
</person-group><article-title>Chetracins E and F, cytotoxic epipolythiodioxopiperazines from the marine-derived fungus <italic toggle="yes">Acrostalagmus luteoalbus</italic> HDN13-530</article-title><source>RSC Adv.</source><year>2018</year><volume>8</volume><fpage>53</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1039/C7RA12063J</pub-id></element-citation></ref><ref id="B39-biomolecules-13-01191"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cao</surname><given-names>J.</given-names></name>
<name><surname>Li</surname><given-names>X.-M.</given-names></name>
<name><surname>Meng</surname><given-names>L.-H.</given-names></name>
<name><surname>Konuklugil</surname><given-names>B.</given-names></name>
<name><surname>Li</surname><given-names>X.</given-names></name>
<name><surname>Li</surname><given-names>H.-L.</given-names></name>
<name><surname>Wang</surname><given-names>B.-G.</given-names></name>
</person-group><article-title>Isolation and characterization of three pairs of indolediketopiperazine enantiomers containing infrequent <italic toggle="yes">N</italic>-methoxy substitution from the marine algal-derived endophytic fungus <italic toggle="yes">Acrostalagmus luteoalbus</italic> TK-43</article-title><source>Bioorg. Chem.</source><year>2019</year><volume>90</volume><fpage>103030</fpage><pub-id pub-id-type="doi">10.1016/j.bioorg.2019.103030</pub-id><pub-id pub-id-type="pmid">31226467</pub-id></element-citation></ref><ref id="B40-biomolecules-13-01191"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cao</surname><given-names>J.</given-names></name>
<name><surname>Li</surname><given-names>X.-M.</given-names></name>
<name><surname>Li</surname><given-names>X.</given-names></name>
<name><surname>Li</surname><given-names>H.-L.</given-names></name>
<name><surname>Konuklugil</surname><given-names>B.</given-names></name>
<name><surname>Wang</surname><given-names>B.-G.</given-names></name>
</person-group><article-title>Uncommon <italic toggle="yes">N</italic>-methoxyindolediketopiperazines from <italic toggle="yes">Acrostalagmus luteoalbus</italic>, a marine algal isolate of endophytic fungus</article-title><source>Chin. J. Chem.</source><year>2021</year><volume>39</volume><fpage>2808</fpage><lpage>2814</lpage><pub-id pub-id-type="doi">10.1002/cjoc.202100368</pub-id></element-citation></ref><ref id="B41-biomolecules-13-01191"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>X.-Y.</given-names></name>
<name><surname>Zhong</surname><given-names>W.-M.</given-names></name>
<name><surname>Zeng</surname><given-names>Q.</given-names></name>
<name><surname>Wang</surname><given-names>F.-Z.</given-names></name>
</person-group><article-title>A preliminary study on the chemical diversity of the deep-sea derived fungus <italic toggle="yes">Acrostalagmus luteoalbus</italic> SCSIO F457 based on OSMAC strategy</article-title><source>Zhongguo Haiyang Yaowu</source><year>2020</year><volume>39</volume><fpage>11</fpage><lpage>19</lpage></element-citation></ref><ref id="B42-biomolecules-13-01191"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Adams</surname><given-names>T.C.</given-names></name>
<name><surname>Payette</surname><given-names>J.N.</given-names></name>
<name><surname>Cheah</surname><given-names>J.H.</given-names></name>
<name><surname>Movassaghi</surname><given-names>M.</given-names></name>
</person-group><article-title>Concise total synthesis of (+)-luteoalbusins A and B</article-title><source>Org. Lett.</source><year>2015</year><volume>17</volume><fpage>4268</fpage><lpage>4271</lpage><pub-id pub-id-type="doi">10.1021/acs.orglett.5b02059</pub-id><?supplied-pmid 26336940?><pub-id pub-id-type="pmid">26336940</pub-id></element-citation></ref><ref id="B43-biomolecules-13-01191"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Feng</surname><given-names>Y.</given-names></name>
<name><surname>Blunt</surname><given-names>J.W.</given-names></name>
<name><surname>Cole</surname><given-names>A.L.J.</given-names></name>
<name><surname>Munro</surname><given-names>M.H.G.</given-names></name>
</person-group><article-title>Novel cytotoxic thiodiketopiperazine derivatives from a <italic toggle="yes">Tilachlidium</italic> sp.</article-title><source>J. Nat. Prod.</source><year>2004</year><volume>67</volume><fpage>2090</fpage><lpage>2092</lpage><pub-id pub-id-type="doi">10.1021/np030326w</pub-id><pub-id pub-id-type="pmid">15620259</pub-id></element-citation></ref><ref id="B44-biomolecules-13-01191"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dong</surname><given-names>J.-Y.</given-names></name>
<name><surname>He</surname><given-names>H.-P.</given-names></name>
<name><surname>Shen</surname><given-names>Y.-M.</given-names></name>
<name><surname>Zhang</surname><given-names>K.-Q.</given-names></name>
</person-group><article-title>Nematicidal epipolysulfanyldioxopiperazines from <italic toggle="yes">Gliocladium roseum</italic></article-title><source>J. Nat. Prod.</source><year>2005</year><volume>68</volume><fpage>1510</fpage><lpage>1513</lpage><pub-id pub-id-type="doi">10.1021/np0502241</pub-id><pub-id pub-id-type="pmid">16252916</pub-id></element-citation></ref><ref id="B45-biomolecules-13-01191"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fujimoto</surname><given-names>H.</given-names></name>
<name><surname>Sumino</surname><given-names>M.</given-names></name>
<name><surname>Okuyama</surname><given-names>E.</given-names></name>
<name><surname>Ishibashi</surname><given-names>M.</given-names></name>
</person-group><article-title>Immunomodulatory constituents from an ascomycete, <italic toggle="yes">Chaetomium seminudum</italic></article-title><source>J. Nat. Prod.</source><year>2004</year><volume>67</volume><fpage>98</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1021/np0302201</pub-id><?supplied-pmid 14738397?><pub-id pub-id-type="pmid">14738397</pub-id></element-citation></ref><ref id="B46-biomolecules-13-01191"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Marmouzi</surname><given-names>I.</given-names></name>
<name><surname>El Abbes Faouzi</surname><given-names>M.</given-names></name>
<name><surname>Saidi</surname><given-names>N.</given-names></name>
<name><surname>Cherrah</surname><given-names>Y.</given-names></name>
<name><surname>Rehberg</surname><given-names>N.</given-names></name>
<name><surname>Ebada</surname><given-names>S.S.</given-names></name>
<name><surname>Ebrahim</surname><given-names>W.</given-names></name>
<name><surname>Kalscheuer</surname><given-names>R.</given-names></name>
<name><surname>Proksch</surname><given-names>P.</given-names></name>
</person-group><article-title>Bioactive secondary metabolites from <italic toggle="yes">Chaetomium globosum</italic>, an endophyte from the Moroccan plant <italic toggle="yes">Avena sativa</italic></article-title><source>Chem. Nat. Compd.</source><year>2017</year><volume>53</volume><fpage>1208</fpage><lpage>1211</lpage><pub-id pub-id-type="doi">10.1007/s10600-017-2242-6</pub-id></element-citation></ref><ref id="B47-biomolecules-13-01191"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhai</surname><given-names>Y.-J.</given-names></name>
<name><surname>Huo</surname><given-names>G.-M.</given-names></name>
<name><surname>Zhang</surname><given-names>Q.</given-names></name>
<name><surname>Li</surname><given-names>D.</given-names></name>
<name><surname>Wang</surname><given-names>D.-C.</given-names></name>
<name><surname>Qi</surname><given-names>J.-Z.</given-names></name>
<name><surname>Han</surname><given-names>W.-B.</given-names></name>
<name><surname>Gao</surname><given-names>J.-M.</given-names></name>
</person-group><article-title>Phaeosphaones: Tyrosinase inhibitory thiodiketopiperazines from an endophytic <italic toggle="yes">Phaeosphaeria fuckelii</italic></article-title><source>J. Nat. Prod.</source><year>2020</year><volume>83</volume><fpage>1592</fpage><lpage>1597</lpage><pub-id pub-id-type="doi">10.1021/acs.jnatprod.0c00046</pub-id><pub-id pub-id-type="pmid">32342692</pub-id></element-citation></ref><ref id="B48-biomolecules-13-01191"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>L.</given-names></name>
<name><surname>Li</surname><given-names>D.</given-names></name>
<name><surname>Luan</surname><given-names>Y.</given-names></name>
<name><surname>Gu</surname><given-names>Q.</given-names></name>
<name><surname>Zhu</surname><given-names>T.</given-names></name>
</person-group><article-title>Cytotoxic metabolites from the Antarctic psychrophilic fungus <italic toggle="yes">Oidiodendron truncatum</italic></article-title><source>J. Nat. Prod.</source><year>2012</year><volume>75</volume><fpage>920</fpage><lpage>927</lpage><pub-id pub-id-type="doi">10.1021/np3000443</pub-id><pub-id pub-id-type="pmid">22583079</pub-id></element-citation></ref><ref id="B49-biomolecules-13-01191"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wei</surname><given-names>W.</given-names></name>
<name><surname>Jiang</surname><given-names>N.</given-names></name>
<name><surname>Mei</surname><given-names>Y.N.</given-names></name>
<name><surname>Chu</surname><given-names>Y.L.</given-names></name>
<name><surname>Ge</surname><given-names>H.M.</given-names></name>
<name><surname>Song</surname><given-names>Y.C.</given-names></name>
<name><surname>Ng</surname><given-names>S.W.</given-names></name>
<name><surname>Tan</surname><given-names>R.X.</given-names></name>
</person-group><article-title>An antibacterial metabolite from <italic toggle="yes">Lasiodiplodia pseudotheobromae</italic> F2</article-title><source>Phytochemistry</source><year>2014</year><volume>100</volume><fpage>103</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1016/j.phytochem.2014.01.003</pub-id><pub-id pub-id-type="pmid">24529576</pub-id></element-citation></ref><ref id="B50-biomolecules-13-01191"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Arora</surname><given-names>P.</given-names></name>
<name><surname>Wani</surname><given-names>Z.A.</given-names></name>
<name><surname>Nalli</surname><given-names>Y.</given-names></name>
<name><surname>Ali</surname><given-names>A.</given-names></name>
<name><surname>Riyaz-Ul-Hassan</surname><given-names>S.</given-names></name>
</person-group><article-title>Antimicrobial potential of thiodiketopiperazine derivatives produced by <italic toggle="yes">Phoma</italic> sp., an endophyte of <italic toggle="yes">Glycyrrhiza glabra</italic> Linn</article-title><source>Microb. Ecology</source><year>2016</year><volume>72</volume><fpage>802</fpage><lpage>812</lpage><pub-id pub-id-type="doi">10.1007/s00248-016-0805-x</pub-id></element-citation></ref><ref id="B51-biomolecules-13-01191"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Scharf</surname><given-names>D.H.</given-names></name>
<name><surname>Remme</surname><given-names>N.</given-names></name>
<name><surname>Habel</surname><given-names>A.</given-names></name>
<name><surname>Chankhamjon</surname><given-names>P.</given-names></name>
<name><surname>Scherlach</surname><given-names>K.</given-names></name>
<name><surname>Heinekamp</surname><given-names>T.</given-names></name>
<name><surname>Hortschansky</surname><given-names>P.</given-names></name>
<name><surname>Brakhage</surname><given-names>A.A.</given-names></name>
<name><surname>Hertweck</surname><given-names>C.</given-names></name>
</person-group><article-title>A Dedicated glutathione <italic toggle="yes">S</italic>-transferase mediates carbon-sulfur bond formation in gliotoxin biosynthesis</article-title><source>J. Am. Chem. Soc.</source><year>2011</year><volume>133</volume><fpage>12322</fpage><lpage>12325</lpage><pub-id pub-id-type="doi">10.1021/ja201311d</pub-id><pub-id pub-id-type="pmid">21749092</pub-id></element-citation></ref><ref id="B52-biomolecules-13-01191"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhao</surname><given-names>P.</given-names></name>
<name><surname>Xue</surname><given-names>Y.</given-names></name>
<name><surname>Li</surname><given-names>J.</given-names></name>
<name><surname>Li</surname><given-names>X.</given-names></name>
<name><surname>Zu</surname><given-names>X.</given-names></name>
<name><surname>Zhao</surname><given-names>Z.</given-names></name>
<name><surname>Quan</surname><given-names>C.</given-names></name>
<name><surname>Gao</surname><given-names>W.</given-names></name>
<name><surname>Feng</surname><given-names>S.</given-names></name>
</person-group><article-title>Non-lipopeptide fungi-derived peptide antibiotics developed since 2000</article-title><source>Biotechnol. Lett.</source><year>2019</year><volume>41</volume><fpage>651</fpage><lpage>673</lpage><pub-id pub-id-type="doi">10.1007/s10529-019-02677-3</pub-id><?supplied-pmid 31020454?><pub-id pub-id-type="pmid">31020454</pub-id></element-citation></ref><ref id="B53-biomolecules-13-01191"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Scharf</surname><given-names>D.H.</given-names></name>
<name><surname>Heinekamp</surname><given-names>T.</given-names></name>
<name><surname>Remme</surname><given-names>N.</given-names></name>
<name><surname>Hortschansky</surname><given-names>P.</given-names></name>
<name><surname>Brakhage</surname><given-names>A.A.</given-names></name>
<name><surname>Hertweck</surname><given-names>C.</given-names></name>
</person-group><article-title>Biosynthesis and function of gliotoxin in <italic toggle="yes">Aspergillus fumigatus</italic></article-title><source>Appl. Microbiol. Biotechnol.</source><year>2012</year><volume>93</volume><fpage>467</fpage><lpage>472</lpage><pub-id pub-id-type="doi">10.1007/s00253-011-3689-1</pub-id><pub-id pub-id-type="pmid">22094977</pub-id></element-citation></ref><ref id="B54-biomolecules-13-01191"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kim</surname><given-names>J.</given-names></name>
<name><surname>Movassaghi</surname><given-names>M.</given-names></name>
</person-group><article-title>Biogenetically-inspired total synthesis of epidithiodiketopiperazines and related alkaloids</article-title><source>Acc. Chem. Res.</source><year>2015</year><volume>48</volume><fpage>1159</fpage><lpage>1171</lpage><pub-id pub-id-type="doi">10.1021/ar500454v</pub-id><pub-id pub-id-type="pmid">25843276</pub-id></element-citation></ref><ref id="B55-biomolecules-13-01191"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Scharf</surname><given-names>D.H.</given-names></name>
<name><surname>Remme</surname><given-names>N.</given-names></name>
<name><surname>Heinekamp</surname><given-names>T.</given-names></name>
<name><surname>Hortschansky</surname><given-names>P.</given-names></name>
<name><surname>Brakhage</surname><given-names>A.A.</given-names></name>
<name><surname>Hertweck</surname><given-names>C.</given-names></name>
</person-group><article-title>Transannular disulfide formation in gliotoxin biosynthesis and its role in self-resistance of the human pathogen <italic toggle="yes">Aspergillus fumigatus</italic></article-title><source>J. Am. Chem. Soc.</source><year>2010</year><volume>132</volume><fpage>10136</fpage><lpage>10141</lpage><pub-id pub-id-type="doi">10.1021/ja103262m</pub-id><pub-id pub-id-type="pmid">20593880</pub-id></element-citation></ref><ref id="B56-biomolecules-13-01191"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sun</surname><given-names>S.</given-names></name>
<name><surname>Dai</surname><given-names>X.</given-names></name>
<name><surname>Sun</surname><given-names>J.</given-names></name>
<name><surname>Bu</surname><given-names>X.</given-names></name>
<name><surname>Weng</surname><given-names>C.</given-names></name>
<name><surname>Li</surname><given-names>H.</given-names></name>
<name><surname>Zhu</surname><given-names>H.</given-names></name>
</person-group><article-title>A diketopiperazine factor from <italic toggle="yes">Rheinheimera aquimaris</italic> QSI02 exhibits anti-quorum sensing activity</article-title><source>Sci. Rep.</source><year>2016</year><volume>6</volume><fpage>39637</fpage><pub-id pub-id-type="doi">10.1038/srep39637</pub-id><?supplied-pmid 28000767?><pub-id pub-id-type="pmid">28000767</pub-id></element-citation></ref><ref id="B57-biomolecules-13-01191"><label>57.</label><element-citation publication-type="patent"><person-group person-group-type="author">
<name><surname>Zhu</surname><given-names>H.</given-names></name>
<name><surname>Sun</surname><given-names>S.</given-names></name>
<name><surname>Li</surname><given-names>H.</given-names></name>
<name><surname>Sun</surname><given-names>J.</given-names></name>
<name><surname>Liu</surname><given-names>A.</given-names></name>
<name><surname>Zhou</surname><given-names>W.</given-names></name>
</person-group><article-title>Preparation, structural identification and application of quorum sensing inhibitor</article-title><patent>CN105130963</patent><day>9</day><month>December</month><year>2015</year></element-citation></ref><ref id="B58-biomolecules-13-01191"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lu</surname><given-names>X.</given-names></name>
<name><surname>Zhang</surname><given-names>M.</given-names></name>
<name><surname>Qiu</surname><given-names>Y.</given-names></name>
<name><surname>Liu</surname><given-names>X.</given-names></name>
<name><surname>Wang</surname><given-names>C.</given-names></name>
<name><surname>Chen</surname><given-names>J.</given-names></name>
<name><surname>Zhang</surname><given-names>H.</given-names></name>
<name><surname>Wei</surname><given-names>B.</given-names></name>
<name><surname>Yu</surname><given-names>Y.</given-names></name>
<name><surname>Ying</surname><given-names>Y.</given-names></name>
<etal/>
</person-group><article-title><italic toggle="yes">&#x003b1;</italic>-Glucosidase inhibitors from two mangrove-derived actinomycetes</article-title><source>Molecules</source><year>2023</year><volume>28</volume><elocation-id>3822</elocation-id><pub-id pub-id-type="doi">10.3390/molecules28093822</pub-id><pub-id pub-id-type="pmid">37175232</pub-id></element-citation></ref><ref id="B59-biomolecules-13-01191"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhao</surname><given-names>D.</given-names></name>
<name><surname>Cao</surname><given-names>F.</given-names></name>
<name><surname>Guo</surname><given-names>X.-J.</given-names></name>
<name><surname>Zhang</surname><given-names>Y.-R.</given-names></name>
<name><surname>Kang</surname><given-names>Z.</given-names></name>
<name><surname>Zhu</surname><given-names>H.-J.</given-names></name>
</person-group><article-title>Antibacterial indole alkaloids and anthraquinones from a sewage-derived fungus <italic toggle="yes">Eurotium</italic> sp.</article-title><source>Chem. Nat. Compd.</source><year>2018</year><volume>54</volume><fpage>399</fpage><lpage>401</lpage><pub-id pub-id-type="doi">10.1007/s10600-018-2361-8</pub-id></element-citation></ref><ref id="B60-biomolecules-13-01191"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Meng</surname><given-names>L.-H.</given-names></name>
<name><surname>Du</surname><given-names>F.-Y.</given-names></name>
<name><surname>Li</surname><given-names>X.-M.</given-names></name>
<name><surname>Pedpradab</surname><given-names>P.</given-names></name>
<name><surname>Xu</surname><given-names>G.-M.</given-names></name>
<name><surname>Wang</surname><given-names>B.-G.</given-names></name>
</person-group><article-title>Rubrumazines A-C, indolediketopiperazines of the isoechinulin class from <italic toggle="yes">Eurotium rubrum</italic> MA-150, a fungus obtained from marine mangrove-derived rhizospheric soil</article-title><source>J. Nat. Prod.</source><year>2015</year><volume>78</volume><fpage>909</fpage><lpage>913</lpage><pub-id pub-id-type="doi">10.1021/np5007839</pub-id><?supplied-pmid 25730346?><pub-id pub-id-type="pmid">25730346</pub-id></element-citation></ref><ref id="B61-biomolecules-13-01191"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tian</surname><given-names>S.-Z.</given-names></name>
<name><surname>Pu</surname><given-names>X.</given-names></name>
<name><surname>Luo</surname><given-names>G.</given-names></name>
<name><surname>Zhao</surname><given-names>L.-X.</given-names></name>
<name><surname>Xu</surname><given-names>L.-H.</given-names></name>
<name><surname>Li</surname><given-names>W.-J.</given-names></name>
<name><surname>Luo</surname><given-names>Y.</given-names></name>
</person-group><article-title>Isolation and characterization of new <italic toggle="yes">p</italic>-terphenyls with antifungal, antibacterial, and antioxidant activities from halophilic actinomycete <italic toggle="yes">Nocardiopsis gilva</italic> YIM 90087</article-title><source>J. Agric. Food Chem.</source><year>2013</year><volume>61</volume><fpage>3006</fpage><lpage>3012</lpage><pub-id pub-id-type="doi">10.1021/jf400718w</pub-id><?supplied-pmid 23441911?><pub-id pub-id-type="pmid">23441911</pub-id></element-citation></ref><ref id="B62-biomolecules-13-01191"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhu</surname><given-names>J.</given-names></name>
<name><surname>Jiang</surname><given-names>W.</given-names></name>
<name><surname>Miao</surname><given-names>L.</given-names></name>
<name><surname>Jin</surname><given-names>C.</given-names></name>
<name><surname>Bao</surname><given-names>W.</given-names></name>
</person-group><article-title>Anti-diatom compounds from marine bacterium <italic toggle="yes">Pseudomonas putida</italic></article-title><source>Weishengwu Xuebao</source><year>2013</year><volume>53</volume><fpage>825</fpage><lpage>831</lpage></element-citation></ref><ref id="B63-biomolecules-13-01191"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ortiz-Castro</surname><given-names>R.</given-names></name>
<name><surname>Diaz-Perez</surname><given-names>C.</given-names></name>
<name><surname>Martinez-Trujillo</surname><given-names>M.</given-names></name>
<name><surname>del Rio</surname><given-names>R.E.</given-names></name>
<name><surname>Campos-Garcia</surname><given-names>J.</given-names></name>
<name><surname>Lopez-Bucio</surname><given-names>J.</given-names></name>
</person-group><article-title>Transkingdom signaling based on bacterial cyclodipeptides with auxin activity in plants</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2011</year><volume>108</volume><fpage>7253</fpage><pub-id pub-id-type="doi">10.1073/pnas.1006740108</pub-id><pub-id pub-id-type="pmid">21482761</pub-id></element-citation></ref><ref id="B64-biomolecules-13-01191"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>G.</given-names></name>
<name><surname>Dai</surname><given-names>S.</given-names></name>
<name><surname>Chen</surname><given-names>M.</given-names></name>
<name><surname>Wu</surname><given-names>H.</given-names></name>
<name><surname>Xie</surname><given-names>L.</given-names></name>
<name><surname>Luo</surname><given-names>X.</given-names></name>
<name><surname>Li</surname><given-names>X.</given-names></name>
</person-group><article-title>Two diketopiperazine cyclo(Pro-Phe) isomers from marine bacterium <italic toggle="yes">Bacillus subtilis</italic> sp. 13-2</article-title><source>Chem. Nat. Compd.</source><year>2010</year><volume>46</volume><fpage>583</fpage><lpage>585</lpage><pub-id pub-id-type="doi">10.1007/s10600-010-9680-8</pub-id></element-citation></ref><ref id="B65-biomolecules-13-01191"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rhee</surname><given-names>K.-H.</given-names></name>
</person-group><article-title>Cyclic dipeptides exhibit synergistic, broad spectrum antimicrobial effects and have anti-mutagenic properties</article-title><source>Int. J. Antimicrob. Agents</source><year>2004</year><volume>24</volume><fpage>423</fpage><lpage>427</lpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2004.05.005</pub-id><pub-id pub-id-type="pmid">15519471</pub-id></element-citation></ref><ref id="B66-biomolecules-13-01191"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kwak</surname><given-names>M.-K.</given-names></name>
<name><surname>Liu</surname><given-names>R.</given-names></name>
<name><surname>Kim</surname><given-names>M.-K.</given-names></name>
<name><surname>Moon</surname><given-names>D.</given-names></name>
<name><surname>Kim</surname><given-names>A.H.</given-names></name>
<name><surname>Song</surname><given-names>S.-H.</given-names></name>
<name><surname>Kang</surname><given-names>S.-O.</given-names></name>
</person-group><article-title>Cyclic dipeptides from lactic acid bacteria inhibit the proliferation of pathogenic fungi</article-title><source>J. Microbiol.</source><year>2014</year><volume>52</volume><fpage>64</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1007/s12275-014-3520-7</pub-id><pub-id pub-id-type="pmid">24390839</pub-id></element-citation></ref><ref id="B67-biomolecules-13-01191"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kumar</surname><given-names>N.</given-names></name>
<name><surname>Mohandas</surname><given-names>C.</given-names></name>
<name><surname>Nambisan</surname><given-names>B.</given-names></name>
<name><surname>Kumar</surname><given-names>D.R.S.</given-names></name>
<name><surname>Lankalapalli</surname><given-names>R.S.</given-names></name>
</person-group><article-title>Isolation of proline-based cyclic dipeptides from <italic toggle="yes">Bacillus</italic> sp. N strain associated with rhabitid entomopathogenic nematode and its antimicrobial properties</article-title><source>World J. Microbiol. Biotechnol.</source><year>2013</year><volume>29</volume><fpage>355</fpage><lpage>364</lpage><pub-id pub-id-type="doi">10.1007/s11274-012-1189-9</pub-id><pub-id pub-id-type="pmid">23065379</pub-id></element-citation></ref><ref id="B68-biomolecules-13-01191"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Alshaibani</surname><given-names>M.M.</given-names></name>
<name><surname>MohamadZin</surname><given-names>N.</given-names></name>
<name><surname>Jalil</surname><given-names>J.</given-names></name>
<name><surname>Sidik</surname><given-names>N.M.</given-names></name>
<name><surname>Ahmad</surname><given-names>S.J.</given-names></name>
<name><surname>Karna</surname><given-names>N.</given-names></name>
<name><surname>Edrada-Ebel</surname><given-names>R.</given-names></name>
</person-group><article-title>Isolation, purification, and characterization of five active diketopiperazine derivatives from endophytic <italic toggle="yes">Streptornyces</italic> SUK 25 with antimicrobial and cytotoxic activities</article-title><source>J. Microbiol. Biotechnol.</source><year>2017</year><volume>27</volume><fpage>1249</fpage><lpage>1256</lpage><pub-id pub-id-type="doi">10.4014/jmb.1608.08032</pub-id><pub-id pub-id-type="pmid">28535606</pub-id></element-citation></ref><ref id="B69-biomolecules-13-01191"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Brauns</surname><given-names>S.C.</given-names></name>
<name><surname>Milne</surname><given-names>P.</given-names></name>
<name><surname>Naude</surname><given-names>R.</given-names></name>
<name><surname>van de Venter</surname><given-names>M.</given-names></name>
</person-group><article-title>Selected cyclic dipeptides inhibit cancer cell growth and induce apoptosis in HT-29 colon cancer cells</article-title><source>Anticancer Res.</source><year>2004</year><volume>24</volume><fpage>1713</fpage><lpage>1719</lpage><pub-id pub-id-type="pmid">15274345</pub-id></element-citation></ref><ref id="B70-biomolecules-13-01191"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Brauns</surname><given-names>S.C.</given-names></name>
<name><surname>Dealtry</surname><given-names>G.</given-names></name>
<name><surname>Milne</surname><given-names>P.</given-names></name>
<name><surname>Naude</surname><given-names>R.</given-names></name>
<name><surname>Van De Venter</surname><given-names>M.</given-names></name>
</person-group><article-title>Caspase-3 activation and induction of PARP cleavage by cyclic dipeptide cyclo(Phe-Pro) in HT-29 cells</article-title><source>Anticancer Res.</source><year>2005</year><volume>25</volume><fpage>4197</fpage><lpage>4202</lpage><pub-id pub-id-type="pmid">16309216</pub-id></element-citation></ref><ref id="B71-biomolecules-13-01191"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rhee</surname><given-names>K.-H.</given-names></name>
</person-group><article-title>Inhibition of DNA topoisomerase I by cyclo(L-prolyl-L-phenylalanyl) isolated from <italic toggle="yes">Streptomyces</italic> sp. AMLK-335</article-title><source>J. Microbiol. Biotechnol.</source><year>2002</year><volume>12</volume><fpage>1013</fpage><lpage>1016</lpage></element-citation></ref><ref id="B72-biomolecules-13-01191"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>X.</given-names></name>
<name><surname>Dobretsov</surname><given-names>S.</given-names></name>
<name><surname>Xu</surname><given-names>Y.</given-names></name>
<name><surname>Xiao</surname><given-names>X.</given-names></name>
<name><surname>Hungi</surname><given-names>O.S.</given-names></name>
<name><surname>Qian</surname><given-names>P.-Y.</given-names></name>
</person-group><article-title>Antifouling diketopiperazines produced by a deep-sea bacterium, <italic toggle="yes">Streptomyces fungicidicus</italic></article-title><source>Biofouling</source><year>2006</year><volume>22</volume><fpage>201</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1080/08927010600780771</pub-id><?supplied-pmid 17290864?><pub-id pub-id-type="pmid">17290864</pub-id></element-citation></ref><ref id="B73-biomolecules-13-01191"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Qi</surname><given-names>S.-H.</given-names></name>
<name><surname>Xu</surname><given-names>Y.</given-names></name>
<name><surname>Gao</surname><given-names>J.</given-names></name>
<name><surname>Qian</surname><given-names>P.-Y.</given-names></name>
<name><surname>Zhang</surname><given-names>S.</given-names></name>
</person-group><article-title>Antibacterial and antilarval compounds from marine bacterium <italic toggle="yes">Pseudomonas rhizosphaerae</italic></article-title><source>Ann. Microbiol.</source><year>2009</year><volume>59</volume><fpage>229</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1007/BF03178321</pub-id></element-citation></ref><ref id="B74-biomolecules-13-01191"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Takaya</surname><given-names>Y.</given-names></name>
<name><surname>Furukawa</surname><given-names>T.</given-names></name>
<name><surname>Miura</surname><given-names>S.</given-names></name>
<name><surname>Akutagawa</surname><given-names>T.</given-names></name>
<name><surname>Hotta</surname><given-names>Y.</given-names></name>
<name><surname>Ishikawa</surname><given-names>N.</given-names></name>
<name><surname>Niwa</surname><given-names>M.</given-names></name>
</person-group><article-title>Antioxidant constituents in distillation residue of awamori spirits</article-title><source>J. Agric. Food Chem.</source><year>2007</year><volume>55</volume><fpage>75</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1021/jf062029d</pub-id><pub-id pub-id-type="pmid">17199316</pub-id></element-citation></ref><ref id="B75-biomolecules-13-01191"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lin</surname><given-names>W.-X.</given-names></name>
<name><surname>Xie</surname><given-names>C.-L.</given-names></name>
<name><surname>Zhou</surname><given-names>M.</given-names></name>
<name><surname>Xia</surname><given-names>M.-L.</given-names></name>
<name><surname>Zhou</surname><given-names>T.-T.</given-names></name>
<name><surname>Chen</surname><given-names>H.-F.</given-names></name>
<name><surname>Yang</surname><given-names>X.-W.</given-names></name>
<name><surname>Yang</surname><given-names>Q.</given-names></name>
</person-group><article-title>Chemical constituents from the deep sea-derived <italic toggle="yes">Streptomyces xiamenensis</italic> MCCC 1A01570 and their effects on RXR&#x003b1; transcriptional regulation</article-title><source>Nat. Prod. Res.</source><year>2020</year><volume>34</volume><fpage>1461</fpage><lpage>1464</lpage><pub-id pub-id-type="doi">10.1080/14786419.2018.1508148</pub-id><pub-id pub-id-type="pmid">30270742</pub-id></element-citation></ref><ref id="B76-biomolecules-13-01191"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yang</surname><given-names>B.</given-names></name>
<name><surname>Huang</surname><given-names>J.</given-names></name>
<name><surname>Lin</surname><given-names>X.</given-names></name>
<name><surname>Zhang</surname><given-names>Y.</given-names></name>
<name><surname>Tao</surname><given-names>H.</given-names></name>
<name><surname>Liu</surname><given-names>Y.</given-names></name>
</person-group><article-title>A new diketopiperazine from the marine sponge <italic toggle="yes">Callyspongia</italic> species</article-title><source>Rec. Nat. Prod.</source><year>2016</year><volume>10</volume><fpage>117</fpage><lpage>121</lpage></element-citation></ref><ref id="B77-biomolecules-13-01191"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hou</surname><given-names>Y.</given-names></name>
<name><surname>Sun</surname><given-names>S.</given-names></name>
<name><surname>Wu</surname><given-names>L.</given-names></name>
<name><surname>Wang</surname><given-names>X.</given-names></name>
<name><surname>Li</surname><given-names>T.</given-names></name>
<name><surname>Zhang</surname><given-names>M.</given-names></name>
<name><surname>Wang</surname><given-names>J.</given-names></name>
<name><surname>Wang</surname><given-names>L.</given-names></name>
</person-group><article-title>Calcium sensitizers isolated from the edible pine mushroom, <italic toggle="yes">Tricholoma matsutake</italic> (S. Ito &#x00026; Imai) Sing</article-title><source>Z. Naturforsch. C J. Biosci.</source><year>2013</year><volume>68</volume><fpage>113</fpage><lpage>117</lpage><pub-id pub-id-type="pmid">23819306</pub-id></element-citation></ref><ref id="B78-biomolecules-13-01191"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kang</surname><given-names>H.</given-names></name>
<name><surname>Ku</surname><given-names>S.-K.</given-names></name>
<name><surname>Choi</surname><given-names>H.</given-names></name>
<name><surname>Bae</surname><given-names>J.-S.</given-names></name>
</person-group><article-title>Three diketopiperazines from marine-derived bacteria inhibit LPS-induced endothelial inflammatory responses</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2016</year><volume>26</volume><fpage>1873</fpage><lpage>1876</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2016.03.030</pub-id><pub-id pub-id-type="pmid">26988307</pub-id></element-citation></ref><ref id="B79-biomolecules-13-01191"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jung</surname><given-names>B.</given-names></name>
<name><surname>Ku</surname><given-names>S.-K.</given-names></name>
<name><surname>Gao</surname><given-names>M.</given-names></name>
<name><surname>Kim</surname><given-names>K.-M.</given-names></name>
<name><surname>Han</surname><given-names>M.-S.</given-names></name>
<name><surname>Choi</surname><given-names>H.</given-names></name>
<name><surname>Bae</surname><given-names>J.-S.</given-names></name>
</person-group><article-title>Suppressive effects of three diketopiperazines from marine-derived bacteria on TGFBIp-mediated septic responses in human endothelial cells and mice</article-title><source>Arch. Pharmacal Res.</source><year>2016</year><volume>39</volume><fpage>843</fpage><lpage>854</lpage><pub-id pub-id-type="doi">10.1007/s12272-016-0743-7</pub-id></element-citation></ref><ref id="B80-biomolecules-13-01191"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Maglangit</surname><given-names>F.</given-names></name>
<name><surname>Kyeremeh</surname><given-names>K.</given-names></name>
<name><surname>Deng</surname><given-names>H.</given-names></name>
</person-group><article-title>Deletion of the accramycin pathway-specific regulatory gene <italic toggle="yes">accJ</italic> activates the production of unrelated polyketide metabolites</article-title><source>Nat. Prod. Res.</source><year>2022</year><volume>37</volume><fpage>2753</fpage><lpage>2758</lpage><pub-id pub-id-type="doi">10.1080/14786419.2022.2126466</pub-id><pub-id pub-id-type="pmid">36125461</pub-id></element-citation></ref><ref id="B81-biomolecules-13-01191"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fujimoto</surname><given-names>H.</given-names></name>
<name><surname>Sumino</surname><given-names>M.</given-names></name>
<name><surname>Nagano</surname><given-names>J.</given-names></name>
<name><surname>Natori</surname><given-names>H.</given-names></name>
<name><surname>Okuyama</surname><given-names>E.</given-names></name>
<name><surname>Yamazaki</surname><given-names>M.</given-names></name>
</person-group><article-title>Immunomodulatory constituents from three <italic toggle="yes">Ascomycetes</italic>, <italic toggle="yes">Gelasinospora heterospora</italic>, <italic toggle="yes">G. multiforis</italic>, and <italic toggle="yes">G. longispora</italic></article-title><source>Chem. Pharm. Bull.</source><year>1999</year><volume>47</volume><fpage>71</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1248/cpb.47.71</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="biomolecules-13-01191-f001"><label>Figure 1</label><caption><p>Chemical structures of compounds <bold>1</bold>&#x02013;<bold>6</bold> [<xref rid="B19-biomolecules-13-01191" ref-type="bibr">19</xref>,<xref rid="B20-biomolecules-13-01191" ref-type="bibr">20</xref>,<xref rid="B21-biomolecules-13-01191" ref-type="bibr">21</xref>,<xref rid="B22-biomolecules-13-01191" ref-type="bibr">22</xref>].</p></caption><graphic xlink:href="biomolecules-13-01191-g001" position="float"/></fig><fig position="float" id="biomolecules-13-01191-f002"><label>Figure 2</label><caption><p>Presumed biosynthesis pathway of compounds <bold>1</bold>&#x02013;<bold>6</bold> [<xref rid="B22-biomolecules-13-01191" ref-type="bibr">22</xref>].</p></caption><graphic xlink:href="biomolecules-13-01191-g002" position="float"/></fig><fig position="float" id="biomolecules-13-01191-f003"><label>Figure 3</label><caption><p>Chemical structures of compounds <bold>7</bold>&#x02013;<bold>34</bold> [<xref rid="B34-biomolecules-13-01191" ref-type="bibr">34</xref>,<xref rid="B37-biomolecules-13-01191" ref-type="bibr">37</xref>,<xref rid="B38-biomolecules-13-01191" ref-type="bibr">38</xref>,<xref rid="B39-biomolecules-13-01191" ref-type="bibr">39</xref>,<xref rid="B40-biomolecules-13-01191" ref-type="bibr">40</xref>,<xref rid="B41-biomolecules-13-01191" ref-type="bibr">41</xref>].</p></caption><graphic xlink:href="biomolecules-13-01191-g003" position="float"/></fig><fig position="float" id="biomolecules-13-01191-f004"><label>Figure 4</label><caption><p>Proposed biosynthesis of compounds <bold>7</bold>&#x02013;<bold>33</bold> [<xref rid="B40-biomolecules-13-01191" ref-type="bibr">40</xref>,<xref rid="B48-biomolecules-13-01191" ref-type="bibr">48</xref>,<xref rid="B51-biomolecules-13-01191" ref-type="bibr">51</xref>,<xref rid="B52-biomolecules-13-01191" ref-type="bibr">52</xref>,<xref rid="B53-biomolecules-13-01191" ref-type="bibr">53</xref>,<xref rid="B54-biomolecules-13-01191" ref-type="bibr">54</xref>,<xref rid="B55-biomolecules-13-01191" ref-type="bibr">55</xref>].</p></caption><graphic xlink:href="biomolecules-13-01191-g004" position="float"/></fig><fig position="float" id="biomolecules-13-01191-f005"><label>Figure 5</label><caption><p>Chemical structures of compounds <bold>35</bold>&#x02013;<bold>50</bold> [<xref rid="B9-biomolecules-13-01191" ref-type="bibr">9</xref>,<xref rid="B37-biomolecules-13-01191" ref-type="bibr">37</xref>,<xref rid="B55-biomolecules-13-01191" ref-type="bibr">55</xref>].</p></caption><graphic xlink:href="biomolecules-13-01191-g005" position="float"/></fig><fig position="float" id="biomolecules-13-01191-f006"><label>Figure 6</label><caption><p>Structural types of compounds isolated from <italic toggle="yes">Acrostalagmus</italic> during 1969&#x02013;2022.</p></caption><graphic xlink:href="biomolecules-13-01191-g006" position="float"/></fig><fig position="float" id="biomolecules-13-01191-f007"><label>Figure 7</label><caption><p>Bioactivities of natural products isolated from <italic toggle="yes">Acrostalagmus</italic> during 1969&#x02013;2022. The bold edges mean compounds with strong activities.</p></caption><graphic xlink:href="biomolecules-13-01191-g007" position="float"/></fig><fig position="float" id="biomolecules-13-01191-f008"><label>Figure 8</label><caption><p>Percentage of <italic toggle="yes">Acrostalagmus</italic> isolated compounds with different bioactivities during 1969&#x02013;2022.</p></caption><graphic xlink:href="biomolecules-13-01191-g008" position="float"/></fig><table-wrap position="float" id="biomolecules-13-01191-t001"><object-id pub-id-type="pii">biomolecules-13-01191-t001_Table 1</object-id><label>Table 1</label><caption><p>Compounds isolated from <italic toggle="yes">Acrostalagmus</italic> during 1969&#x02013;2022.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Types</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compounds</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Sources</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Distribution</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Years</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Refs.</th></tr></thead><tbody><tr><td rowspan="3" align="center" valign="middle" colspan="1">Terpenoids</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>1</bold>, <bold>2</bold></td><td rowspan="3" align="center" valign="middle" colspan="1"><italic toggle="yes">Acrostalagmus</italic> sp. NRRL-3481</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">1969</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B19-biomolecules-13-01191" ref-type="bibr">19</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>3</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">1971</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B21-biomolecules-13-01191" ref-type="bibr">21</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>4</bold>&#x02013;<bold>6</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">1974</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B22-biomolecules-13-01191" ref-type="bibr">22</xref>]</td></tr><tr><td rowspan="5" align="center" valign="middle" style="border-top:solid thin" colspan="1">Alkaloids</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1"><bold>7</bold>&#x02013;<bold>9</bold></td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1"><italic toggle="yes">A. cinnabarinus</italic> var. <italic toggle="yes">melinacidinus</italic></td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1972</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">[<xref rid="B33-biomolecules-13-01191" ref-type="bibr">33</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>10</bold>&#x02013;<bold>16</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">Deep-sea sediment-derived fungus <italic toggle="yes">A. luteoalbus</italic> SCSIO F457 (GenBank No. MN860118)</td><td align="center" valign="middle" rowspan="1" colspan="1"> South China Sea</td><td align="center" valign="middle" rowspan="1" colspan="1">2012</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B37-biomolecules-13-01191" ref-type="bibr">37</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>17</bold>&#x02013;<bold>19</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">Soil derived fungus <italic toggle="yes">A. luteoalbus</italic> HDN13-530 (GenBank No. KP969081)</td><td align="center" valign="middle" rowspan="1" colspan="1">Liaodong Bay, China</td><td align="center" valign="middle" rowspan="1" colspan="1">2017</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B38-biomolecules-13-01191" ref-type="bibr">38</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>20</bold>&#x02013;<bold>25</bold></td><td rowspan="2" align="center" valign="middle" colspan="1">Marine green alga <italic toggle="yes">Codium fragile</italic> derived endophytic fungus <italic toggle="yes">A. luteoalbus</italic> TK-43 (GenBank No. MH836621)</td><td rowspan="2" align="center" valign="middle" colspan="1">Sinop, Turkey</td><td align="center" valign="middle" rowspan="1" colspan="1">2019</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B39-biomolecules-13-01191" ref-type="bibr">39</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>26</bold>&#x02013;<bold>34</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">2021</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B40-biomolecules-13-01191" ref-type="bibr">40</xref>]</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Peptides</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1"><bold>35</bold>&#x02013;<bold>37</bold></td><td rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1"> Deep-sea sediment-derived fungus <italic toggle="yes">A. luteoalbus</italic> SCSIO F457 (GenBank No. MN860118)</td><td rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">South China Sea</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">2012</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">[<xref rid="B37-biomolecules-13-01191" ref-type="bibr">37</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>38</bold>&#x02013;<bold>42</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2020</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B41-biomolecules-13-01191" ref-type="bibr">41</xref>]</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Pyranone derivatives</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>43</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1"> Deep-sea sediment-derived fungus <italic toggle="yes">A. luteoalbus</italic> SCSIO F457 (GenBank No. MN860118)</td><td align="center" valign="middle" rowspan="1" colspan="1">South China Sea</td><td align="center" valign="middle" rowspan="1" colspan="1">2020</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B41-biomolecules-13-01191" ref-type="bibr">41</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>44</bold>&#x02013;<bold>46</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antarctic soil derived fungus <italic toggle="yes">A. luteoalbus</italic> CH-6 (Genbank No. MT367202.1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fields Peninsula, Antarctica</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2022</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B9-biomolecules-13-01191" ref-type="bibr">9</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Paulownin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>47</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> Deep-sea sediment-derived fungus <italic toggle="yes">A. luteoalbus</italic> SCSIO F457 (GenBank No. MN860118)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">South China Sea</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2020</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B41-biomolecules-13-01191" ref-type="bibr">41</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Benzene derivatives</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>48</bold>&#x02013;<bold>50</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> Deep-sea sediment-derived fungus <italic toggle="yes">A. luteoalbus</italic> SCSIO F457 (GenBank No. MN860118)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">South China Sea</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2020</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B41-biomolecules-13-01191" ref-type="bibr">41</xref>]</td></tr></tbody></table></table-wrap><table-wrap position="float" id="biomolecules-13-01191-t002"><object-id pub-id-type="pii">biomolecules-13-01191-t002_Table 2</object-id><label>Table 2</label><caption><p>Cytotoxicity of compounds isolated from <italic toggle="yes">Acrostalagmus</italic> during 1969&#x02013;2022.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cell Lines</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compounds</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Values (IC<sub>50</sub>)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Values of Positive Controls (IC<sub>50</sub>)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Pros and Cons</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">P388</td><td rowspan="7" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><bold>1</bold><break/>(&#x003bc;g/mL)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.1</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td rowspan="7" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Pros: Strong and broad spectrum cytotoxicity [<xref rid="B23-biomolecules-13-01191" ref-type="bibr">23</xref>].</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">BXPC-3</td><td align="center" valign="middle" rowspan="1" colspan="1">0.36</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">MCF-7</td><td align="center" valign="middle" rowspan="1" colspan="1">0.33</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">SF268</td><td align="center" valign="middle" rowspan="1" colspan="1">0.24</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">NCI-H460</td><td align="center" valign="middle" rowspan="1" colspan="1">0.24</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">KM20L</td><td align="center" valign="middle" rowspan="1" colspan="1">0.21</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DU-145</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.14</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HL-60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>3</bold> (&#x003bc;M)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>0.60</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.71</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pro: Strong cytotoxicity with the same level as the positive control [<xref rid="B25-biomolecules-13-01191" ref-type="bibr">25</xref>].</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">P388</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>9/12</bold><break/>(&#x003bc;M)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.05/0.25</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pro: Potent cytotoxicity against murine P388 leukemia cells [<xref rid="B35-biomolecules-13-01191" ref-type="bibr">35</xref>,<xref rid="B43-biomolecules-13-01191" ref-type="bibr">43</xref>].</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">SF-268</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><bold>10/11/12</bold>/<break/><bold>13/14</bold> (&#x003bc;M)</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.46 &#x000b1; 0.05/0.59 &#x000b1; 0.03/1.04 &#x000b1; 0.03</bold>/<break/><bold>0.73 &#x000b1; 0.05/2.49 &#x000b1; 0.07</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">4.76 &#x000b1; 0.27</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Pros: Compounds <bold>10</bold>&#x02013;<bold>14</bold> exhibited potent cytotoxicity, and <bold>10</bold> and <bold>11</bold> showed stronger cytotoxicity against all four tested cancer cell lines than that of the positive control cisplatin [<xref rid="B37-biomolecules-13-01191" ref-type="bibr">37</xref>].</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">MCF-7</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.23 &#x000b1; 0.03/0.25 &#x000b1; 0.00/0.91 &#x000b1; 0.03</bold>/<break/><bold>0.23 &#x000b1; 0.03/0.65 &#x000b1; 0.07</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">3.99 &#x000b1; 0.13</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">NCI-H460</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>1.15 &#x000b1; 0.03/1.31 &#x000b1; 0.12</bold>/5.60 &#x000b1; 0.58/<break/>6.57 &#x000b1; 0.81/17.78 &#x000b1; 0.27</td><td align="center" valign="middle" rowspan="1" colspan="1">2.91 &#x000b1; 0.18</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HepG-2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>0.91 &#x000b1; 0.03/1.29 &#x000b1; 0.16</bold>/3.52 &#x000b1; 0.74/<break/><bold>0.53 &#x000b1; 0.04/2.03 &#x000b1; 0.07</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.45 &#x000b1; 0.07</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">A549</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><bold>10/11</bold> (&#x003bc;M)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.33 &#x000b1; 0.59/0.91 &#x000b1; 0.29</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Pro: Prominent cytotoxic activities [<xref rid="B42-biomolecules-13-01191" ref-type="bibr">42</xref>].</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">HeLa</td><td align="center" valign="middle" rowspan="1" colspan="1">1.00 &#x000b1; 0.24/0.52 &#x000b1; 0.15</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HCT116</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.22 &#x000b1; 1.02/0.58 &#x000b1; 0.38</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">L5178Y </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>15/16</bold><break/>(&#x003bc;M)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>0.26/0.82</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pro: Potent cytotoxic activities against murine lymphoma L5178Y cell line, which are more potent than that of the positive control kahalalide F [<xref rid="B46-biomolecules-13-01191" ref-type="bibr">46</xref>].</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">A549</td><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><bold>17/18/19</bold><break/>(&#x003bc;M)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.4/1.9/0.7</td><td align="center" valign="middle" rowspan="1" colspan="1">0.2</td><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Pro: Extensive cytotoxicity, <bold>17</bold> showed stronger activity to H1975 than that of positive drug doxorubicin hydrochloride [<xref rid="B38-biomolecules-13-01191" ref-type="bibr">38</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">HCT116</td><td align="center" valign="middle" rowspan="1" colspan="1">0.4/2.1/0.3</td><td align="center" valign="middle" rowspan="1" colspan="1">0.2</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">K562</td><td align="center" valign="middle" rowspan="1" colspan="1">0.4/1.9/1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.2</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">H1975</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.2</bold>/3.6/0.8</td><td align="center" valign="middle" rowspan="1" colspan="1">0.8</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HL-60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.9/1.9/1.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.02</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">HCT-8</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><bold>19</bold> (&#x003bc;M)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.49 &#x000b1; 0.09</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Pro: Significant cytotoxicity against a panel of cancer cell lines [<xref rid="B48-biomolecules-13-01191" ref-type="bibr">48</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Bel-7402</td><td align="center" valign="middle" rowspan="1" colspan="1">0.38 &#x000b1; 0.03</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">BGC-823</td><td align="center" valign="middle" rowspan="1" colspan="1">0.70 &#x000b1; 0.04</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A2780</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.58 &#x000b1; 0.03</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">HeLa</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><bold>38</bold> (mM)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.92 &#x000b1; 1.55</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Con: Weak activity [<xref rid="B69-biomolecules-13-01191" ref-type="bibr">69</xref>].</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">HT-29</td><td align="center" valign="middle" rowspan="1" colspan="1">4.04 &#x000b1; 1.15</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MCF-7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.53 &#x000b1; 1.26</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">ECA-109</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><bold>42</bold> (inhibition rate at 20 &#x000b5;M)</td><td align="center" valign="middle" rowspan="1" colspan="1">44% </td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Con: Weak activity [<xref rid="B75-biomolecules-13-01191" ref-type="bibr">75</xref>].</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Hela-S3</td><td align="center" valign="middle" rowspan="1" colspan="1">52%</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PANC-1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">55%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr></tbody></table><table-wrap-foot><fn><p>The bold cytotoxic values are stronger than their positive controls.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="biomolecules-13-01191-t003"><object-id pub-id-type="pii">biomolecules-13-01191-t003_Table 3</object-id><label>Table 3</label><caption><p>Antimicrobial activities of compounds isolated from <italic toggle="yes">Acrostalagmus</italic> during 1969&#x02013;2022.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Strains</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compounds</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Values (MIC)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Values of Positive Controls (MIC)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Pros and Cons</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">Cryptococcus neoformans</italic> ATCC 90112</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><bold>1</bold><break/>(&#x003bc;g/mL)</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Pro: Strong activity against fungus <italic toggle="yes">C. neoformans</italic> caused infection in human [<xref rid="B23-biomolecules-13-01191" ref-type="bibr">23</xref>,<xref rid="B24-biomolecules-13-01191" ref-type="bibr">24</xref>].</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">Candida albicans</italic> ATCC 90028</td><td align="center" valign="middle" rowspan="1" colspan="1">8</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Pseudogymnoascus destructans</italic> ATCC MYA 4855</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">methicillin-resistant <italic toggle="yes">Staphylococcus aureus</italic> (MRSA)</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><bold>9</bold><break/>(&#x003bc;g/mL)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.7</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">1.4</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"> Pros: Strong antibacterial activity to MRSA, the activity was double of the positive control [<xref rid="B36-biomolecules-13-01191" ref-type="bibr">36</xref>].</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">vancomycin-resistant <italic toggle="yes">Enterococcus faecium</italic> (VRE) </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.4</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">S. aureus</italic> ATCC29213</td><td rowspan="19" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><bold>12/32</bold> (&#x003bc;M)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.8 &#x000b1; 0.40/5.8 &#x000b1; 0.45</td><td align="center" valign="middle" rowspan="1" colspan="1">0.362 &#x000b1; 0.09</td><td rowspan="19" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Pros: Broad-spectrum antimicrobial activity; Strong activity against MRSA compared with positive control.<break/>Con: Moderate or weak antimicrobial activity to some of the test strains [<xref rid="B50-biomolecules-13-01191" ref-type="bibr">50</xref>].</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">MRSA</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>8.4 &#x000b1; 1.01/5.6 &#x000b1; 0.99</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">9.33 &#x000b1; 2.6</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">Bacillus cereus</italic> IIIM25</td><td align="center" valign="middle" rowspan="1" colspan="1">9.2 &#x000b1; 0.77/9.9 &#x000b1; 0.81</td><td align="center" valign="middle" rowspan="1" colspan="1">0.12 &#x000b1; 0.009</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">Klebsiella pneumoniae</italic> ATCC75388</td><td align="center" valign="middle" rowspan="1" colspan="1">19.1 &#x000b1; 1.1/4.5 &#x000b1; 0.77</td><td align="center" valign="middle" rowspan="1" colspan="1">0.015 &#x000b1; 0.0006</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">Bacillus thuringiensis</italic> MTCC 809</td><td align="center" valign="middle" rowspan="1" colspan="1">14.8 &#x000b1; 0.28/19 &#x000b1; 0.84</td><td align="center" valign="middle" rowspan="1" colspan="1">0.003 &#x000b1; 0.001</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">Yersinia enterocolitica</italic> MTCC840</td><td align="center" valign="middle" rowspan="1" colspan="1">38 &#x000b1; 1.7/65.3 &#x000b1; 1.6</td><td align="center" valign="middle" rowspan="1" colspan="1">3.5 &#x000b1; 0.202</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">Erwinia herbicola</italic> MTCC3609</td><td align="center" valign="middle" rowspan="1" colspan="1">15.4 &#x000b1; 2.7/14.2 &#x000b1; 1.4</td><td align="center" valign="middle" rowspan="1" colspan="1">0.006 &#x000b1; 0.0009</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">Shigella dysenteriae</italic> NCTC 11311</td><td align="center" valign="middle" rowspan="1" colspan="1">82.3 &#x000b1; 1.3/&#x02013;</td><td align="center" valign="middle" rowspan="1" colspan="1">0.006 &#x000b1; 0.0003</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">Lactococcus lactis</italic> MTCC440</td><td align="center" valign="middle" rowspan="1" colspan="1">28.7 &#x000b1; 1.7/39.4 &#x000b1; 1.1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.006 &#x000b1; 0.001</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">S. epidermidis</italic> MTCC35</td><td align="center" valign="middle" rowspan="1" colspan="1">22.6 &#x000b1; 2.2/23.4 &#x000b1; 1.5</td><td align="center" valign="middle" rowspan="1" colspan="1">0.06 &#x000b1; 0.006</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">Alcaligenes faecalis</italic> MTCC126</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02013;/&#x02013;</td><td align="center" valign="middle" rowspan="1" colspan="1">1.2 &#x000b1; 0.06</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">S. warneri</italic> MTCC4436</td><td align="center" valign="middle" rowspan="1" colspan="1">5.05 &#x000b1; 0.4/7.5 &#x000b1; 0.4</td><td align="center" valign="middle" rowspan="1" colspan="1">2.4 &#x000b1; 0.105</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">Pseudomonas fluorescens</italic> MTCC103</td><td align="center" valign="middle" rowspan="1" colspan="1">18.4 &#x000b1; 0.3/26.1 &#x000b1; 2.7</td><td align="center" valign="middle" rowspan="1" colspan="1">0.151 &#x000b1; 0.051</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">Xanthobacter flavus</italic> MTCC 132</td><td align="center" valign="middle" rowspan="1" colspan="1">98.3 &#x000b1; 1.1/&#x02013;</td><td align="center" valign="middle" rowspan="1" colspan="1">2.3 &#x000b1; 0.021</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">S. pyogenes</italic> MTCC442</td><td align="center" valign="middle" rowspan="1" colspan="1">1.8 &#x000b1; 0.2/3.1 &#x000b1; 0.15</td><td align="center" valign="middle" rowspan="1" colspan="1">0.015 &#x000b1; 0.0006</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">Shigella boydii</italic> NCTC9357</td><td align="center" valign="middle" rowspan="1" colspan="1">31.5 &#x000b1; 1.2/26.7 &#x000b1; 0.9</td><td align="center" valign="middle" rowspan="1" colspan="1">1.12 &#x000b1; 0.063</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">Clostridium pasteurianum</italic> MTCC116</td><td align="center" valign="middle" rowspan="1" colspan="1">92.3 &#x000b1; 0.4/54.0 &#x000b1; 0.5</td><td align="center" valign="middle" rowspan="1" colspan="1">0.015 &#x000b1; 0.003</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">Salmonella typhimurium</italic> MTCC98</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02013;/86.2 &#x000b1; 1.9</td><td align="center" valign="middle" rowspan="1" colspan="1">0.015 &#x000b1; 0.003</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">C. albicans</italic> MTCC4748</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02013;/35.8 &#x000b1; 1.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.5 &#x000b1; 0.022</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">C. albicans</italic>
</td><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><bold>10/13/32</bold> (&#x003bc;M)</td><td align="center" valign="middle" rowspan="1" colspan="1">12.5/25/<bold>6.25</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">6.25</td><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Pro: Compound <bold>32</bold> showed broad-spectrum antimicrobial activity.<break/>Con: Weak activity [<xref rid="B9-biomolecules-13-01191" ref-type="bibr">9</xref>].</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">Aeromonas salmonicida</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">12.5/50/<bold>3.125</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">6.25</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">Photobacterium halotolerans</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">-/-/25</td><td align="center" valign="middle" rowspan="1" colspan="1">0.195</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">Pseudomonas fulva</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">-/-/25</td><td align="center" valign="middle" rowspan="1" colspan="1">1.56</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">S. aureus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-/-/25</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.125</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">Escherichia coli</italic>
</td><td rowspan="11" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><bold>16/30/32</bold> (&#x003bc;M)</td><td align="center" valign="middle" rowspan="1" colspan="1">-/-/<bold>8</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">12</td><td rowspan="11" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Pros: Compound <bold>32</bold> showed broad-spectrum antimicrobial activity, and the activity is significant and comparable to that of the positive control; compounds <bold>16</bold> and <bold>30</bold> displayed specific remarkable antibacterial activities toward <italic toggle="yes">Ed. ictaluri</italic> [<xref rid="B40-biomolecules-13-01191" ref-type="bibr">40</xref>].</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">Edwardsiella tarda</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">-/-/<bold>2</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">2</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">Ed. ictaluri</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>5/3/2</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">Aeromonas hydrophila</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">-/-/<bold>4</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">3</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">Micrococcus luteus</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">-/-/33</td><td align="center" valign="middle" rowspan="1" colspan="1">3</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">Pseudomonas aeruginosa</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">-/-/<bold>8</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">6</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">Vibrio alginolyticus</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">-/-/8</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">V. anguillarum</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">-/-/<bold>2</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">3</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">V. harveyi</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">-/-/<bold>4</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">3</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">V. parahemolyticus</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">-/-/<bold>2</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">12</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">V. vulnificus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-/-/33</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Fusarium solani</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>23</bold> (&#x003bc;g/mL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">32</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pro: <bold>23</bold> exhibited specific antifungal activity toward <italic toggle="yes">F. solani</italic> [<xref rid="B39-biomolecules-13-01191" ref-type="bibr">39</xref>].</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">Veillonella parvula</italic>
</td><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><bold>31</bold> (&#x003bc;g/mL)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.25</td><td align="center" valign="middle" rowspan="1" colspan="1">0.12</td><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Pro: <bold>31</bold> exhibited strong antibacterial activity, comparable or even more significant than that of positive control [<xref rid="B49-biomolecules-13-01191" ref-type="bibr">49</xref>].</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">Actinomyces israelii</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">32</td><td align="center" valign="middle" rowspan="1" colspan="1">8</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">Streptococcus</italic> sp.</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.12</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.25</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">Bacteroides vulgatus</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.12</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.5</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Peptostreptococcus</italic> sp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>0.12</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.5</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">E. coli</italic>
</td><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><bold>35</bold> (mg/mL)</td><td align="center" valign="middle" rowspan="1" colspan="1">6.4</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Con: Weak activity [<xref rid="B56-biomolecules-13-01191" ref-type="bibr">56</xref>,<xref rid="B57-biomolecules-13-01191" ref-type="bibr">57</xref>].</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">Chromobacterium violaceum</italic> CV026</td><td align="center" valign="middle" rowspan="1" colspan="1">3.2</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">Pseudomonas aeruginosa</italic> PA01</td><td align="center" valign="middle" rowspan="1" colspan="1">6.4</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">S. aureus</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">3.2</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">C. albicans</italic> 00147</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">B.</italic>
<italic toggle="yes">cereus</italic>
</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><bold>36</bold> (&#x003bc;M)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.56</td><td align="center" valign="middle" rowspan="1" colspan="1">0.78</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Con: Medium activity [<xref rid="B59-biomolecules-13-01191" ref-type="bibr">59</xref>].</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Proteus vulgaris</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.13</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.20</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">Enterococcus faecium</italic> (K-99-38)</td><td rowspan="18" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><bold>38</bold> and cyclo(L-Leu-L-Pro)/<bold>38</bold> (&#x003bc;g/mL)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>1/64</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">64</td><td rowspan="18" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Pro: Combination of <bold>38</bold> and cyclo(L-Leu-L-Pro) displayed prominent antimicrobial activity, much stronger than those of positive controls [<xref rid="B64-biomolecules-13-01191" ref-type="bibr">64</xref>,<xref rid="B65-biomolecules-13-01191" ref-type="bibr">65</xref>].</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">E. faecalis</italic> (K-99-17)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.5/16</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">128</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">E. faecalis</italic> (K-99-258)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.25/32</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;256</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">E. faecalis</italic> (K-01-312)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>2/16</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">128</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">E. faecium</italic> (K-01-511)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.5/32</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">128</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">E. col</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.5</bold>/64</td><td align="center" valign="middle" rowspan="1" colspan="1">32</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">B. subtilis</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>1</bold>/128</td><td align="center" valign="middle" rowspan="1" colspan="1">64</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">Micrococcus luteus</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.25</bold>/64</td><td align="center" valign="middle" rowspan="1" colspan="1">32</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">S. faecalis</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>2</bold>/&#x0003e;256</td><td align="center" valign="middle" rowspan="1" colspan="1">64</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">P. aeruginosa</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>1</bold>/64</td><td align="center" valign="middle" rowspan="1" colspan="1">12.5</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">S. aureus</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.5</bold>/256</td><td align="center" valign="middle" rowspan="1" colspan="1">25</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Penicillin resistant <italic toggle="yes">S. aureus</italic></td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>4</bold>/256</td><td align="center" valign="middle" rowspan="1" colspan="1">64</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">C. albicans</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.25</bold>/64</td><td align="center" valign="middle" rowspan="1" colspan="1">32</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">C. glabrata</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>4</bold>/256</td><td align="center" valign="middle" rowspan="1" colspan="1">16</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">C</italic>
<italic toggle="yes">. tropicalis</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.5</bold>/32</td><td align="center" valign="middle" rowspan="1" colspan="1">128</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Amphotericin B resistant <italic toggle="yes">C. tropicalis</italic></td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.5</bold>/64</td><td align="center" valign="middle" rowspan="1" colspan="1">16</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">Cryptococcus neoformans</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.25</bold>/32</td><td align="center" valign="middle" rowspan="1" colspan="1">16</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Amphotericin B resistant <italic toggle="yes">C. neoformans</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>2</bold>/&#x0003e;256</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">32</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">Ganoderma plantarum</italic>
</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><bold>38/39/40</bold> (mM)</td><td align="center" valign="middle" rowspan="1" colspan="1">6.8/8.2/8.2</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Con: Weak activity [<xref rid="B66-biomolecules-13-01191" ref-type="bibr">66</xref>].</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Candida</italic> sp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">B. subtilis</italic> MTCC2756</td><td rowspan="9" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><bold>38/39</bold> (&#x000b5;g/mL)</td><td align="center" valign="middle" rowspan="1" colspan="1">16/64</td><td align="center" valign="middle" rowspan="1" colspan="1">5</td><td rowspan="9" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Pro: Demonstrated prominent activities against agriculturally important fungi, much higher than the commercial fungicide bavistin [<xref rid="B67-biomolecules-13-01191" ref-type="bibr">67</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">S. aureus</italic> MTCC902</td><td align="center" valign="middle" rowspan="1" colspan="1">16/32</td><td align="center" valign="middle" rowspan="1" colspan="1">5</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">E. coli</italic> MTCC2622</td><td align="center" valign="middle" rowspan="1" colspan="1">8/32</td><td align="center" valign="middle" rowspan="1" colspan="1">5</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">P. aeruginosa</italic> MTCC2642</td><td align="center" valign="middle" rowspan="1" colspan="1">32/-</td><td align="center" valign="middle" rowspan="1" colspan="1">10</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">Aspergillus flavus</italic> MTCC183</td><td align="center" valign="middle" rowspan="1" colspan="1">128/32</td><td align="center" valign="middle" rowspan="1" colspan="1">100</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">C. albicans</italic> MTCC277</td><td align="center" valign="middle" rowspan="1" colspan="1">64/32</td><td align="center" valign="middle" rowspan="1" colspan="1">50</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">Fusarium oxysporum</italic> MTCC284</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>4/8</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">25</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">Rhizoctonia solani</italic> MTCC4634</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>4/8</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">25</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Pencillium expansum</italic> MTCC2006</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>2/4</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MRSA 43300 (inhibition zone)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>40</bold> (mm)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Con: Medium activity [<xref rid="B68-biomolecules-13-01191" ref-type="bibr">68</xref>].</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">S. aureus</italic> ATCC 25923</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1"><bold>43</bold> (&#x000b5;g/mL)</td><td align="center" valign="middle" rowspan="1" colspan="1">25</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Con: Medium activity [<xref rid="B80-biomolecules-13-01191" ref-type="bibr">80</xref>].</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">Enterococcus faecalis</italic> ATCC 29212</td><td align="center" valign="middle" rowspan="1" colspan="1">12.5</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">E. faecium</italic> K59&#x02013;68</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr></tbody></table><table-wrap-foot><fn><p>The bold antimicrobial values are stronger or comparable than their positive controls.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="biomolecules-13-01191-t004"><object-id pub-id-type="pii">biomolecules-13-01191-t004_Table 4</object-id><label>Table 4</label><caption><p>Other bioactivities of compounds isolated from <italic toggle="yes">Acrostalagmus</italic> during 1969&#x02013;2022.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Bioactivities</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cells/Stains/Enzyme</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compounds</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Values</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Values of Positive Controls </th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Pros and Cons</th></tr></thead><tbody><tr><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Plant growth regulator,<break/>inhibition of the germination and growth development at 10<sup>&#x02212;4</sup> M (%)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">Avena coleoptile</italic>
</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<bold>1</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Pro: Significant inhibitory activity, and more active than the commercial herbicide LOGRAN<sup>&#x000ae;</sup> [<xref rid="B26-biomolecules-13-01191" ref-type="bibr">26</xref>,<xref rid="B27-biomolecules-13-01191" ref-type="bibr">27</xref>].</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">Allium cepa</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x0003e;80%</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">65%</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">Hordeum vulgare</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x0003e;80%</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;60%</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Lactuca sativa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>&#x0003e;80%</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003c;60%</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plant growth regulator</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Auxin signaling and plant growth promotion</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>38</bold>
<bold>&#x02013;</bold>
<bold>40</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pro: Established a significant function for DKPs mediating transkingdom signaling between prokaryote and eukaryote [<xref rid="B63-biomolecules-13-01191" ref-type="bibr">63</xref>].</td></tr><tr><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Anti-inflammatory activity<break/>(IC<sub>50</sub>, &#x003bc;M)</td><td align="center" valign="middle" rowspan="1" colspan="1">IL-1&#x003b2;</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<bold>1/2</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.049/69</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Pro: Compound <bold>1</bold> showed potent inhibitory activity to the production of IL-1&#x003b2;. <break/>Con: Compound <bold>2</bold> showed weak activity [<xref rid="B28-biomolecules-13-01191" ref-type="bibr">28</xref>,<xref rid="B29-biomolecules-13-01191" ref-type="bibr">29</xref>,<xref rid="B30-biomolecules-13-01191" ref-type="bibr">30</xref>].</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">TNF-&#x003b1;</td><td align="center" valign="middle" rowspan="1" colspan="1">3.0/11</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Leucine uptake</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11/120</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Inhibition the LPS-induced migration, adhesion, and hyperpermeability of leukocytes</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<bold>42</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Pro: Potential candidate for therapy of the different vascular inflammatory diseases [<xref rid="B78-biomolecules-13-01191" ref-type="bibr">78</xref>,<xref rid="B79-biomolecules-13-01191" ref-type="bibr">79</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Suppress TGFBIp-mediated and CLP-induced septic responses</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Nematicidal activity (ED<sub>50</sub>, &#x000b5;g/mL)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">Caenorhabditis elegans</italic>
</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<bold>13/14</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">200/200 </td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Con: Weak activities [<xref rid="B44-biomolecules-13-01191" ref-type="bibr">44</xref>].</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Panagrellus redivivus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">250/250</td></tr><tr><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Biofilm inhibition at MIC values (%)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">S.aureus</italic>
</td><td rowspan="2" align="center" valign="middle" colspan="1">
<bold>12/32</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">70.3%/<break/>68.8%</td><td rowspan="2" align="center" valign="middle" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Pros: Strong activities [<xref rid="B50-biomolecules-13-01191" ref-type="bibr">50</xref>], <bold>35</bold> displayed stronger biofilm inhibition than that of positive control azithromycin [<xref rid="B56-biomolecules-13-01191" ref-type="bibr">56</xref>,<xref rid="B57-biomolecules-13-01191" ref-type="bibr">57</xref>].</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">S. pyogenes</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">60.75%/<break/>86.4%</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Pseudomonas aeruginosa</italic> PA01</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>35</bold> (1/32 MIC)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>59.9%</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">53.9%</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Immunosuppressive activity, IC<sub>50</sub> value on Con A-(T-cells)-induced or LPS-induced proliferations of mouse splenic lymphocytes (&#x000b5;g/mL)</td><td align="center" valign="middle" rowspan="1" colspan="1">Con A-(T-cells)-induced </td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>15/46</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">24/<bold>0.9</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">2.7</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Pro: Compound <bold>46</bold> showed significant immunosuppressive activity and stronger than that of positive control azathioprine [<xref rid="B81-biomolecules-13-01191" ref-type="bibr">81</xref>]. Con: Weak activity of <bold>15</bold> [<xref rid="B45-biomolecules-13-01191" ref-type="bibr">45</xref>].</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LPS-induced</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>46</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>1.2</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.7</td></tr><tr><td rowspan="10" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Enzyme inhibition (IC<sub>50</sub>, &#x000b5;M)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mushroom<break/>tyrosinase</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>15</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>31.7 &#x000b1; 0.2</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">40.4 &#x000b1; 0.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pro: Stronger than the inhibition of the positive control kojic acid [<xref rid="B47-biomolecules-13-01191" ref-type="bibr">47</xref>].</td></tr><tr><td rowspan="7" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">AChE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>20</bold> and <bold>21</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.5</td><td rowspan="7" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.14</td><td rowspan="9" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Pro: Compounds <bold>35</bold> and <bold>38</bold> with stronger enzyme inhibition than their positive control acarbose [<xref rid="B58-biomolecules-13-01191" ref-type="bibr">58</xref>,<xref rid="B71-biomolecules-13-01191" ref-type="bibr">71</xref>]. Con: Medium or weak activity [<xref rid="B39-biomolecules-13-01191" ref-type="bibr">39</xref>,<xref rid="B40-biomolecules-13-01191" ref-type="bibr">40</xref>].</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>20/21</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.3/13.8</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>22</bold> and <bold>23</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60.7</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>22/23</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">78.8/49.2</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>24</bold> and <bold>25</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">130.5</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>24/25</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">160.6/<break/>121.7</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>26/27</bold>/<break/><bold>28/29</bold></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18.9/32/<break/>8.4/32</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">&#x003b1;</italic>-Glucosidase</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>35</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">164.5 &#x000b1; 15.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">422.3 &#x000b1; 8.44</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Topoisomerase I</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>38</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>13</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hsp90 inhibition at the concentration of 0.5 &#x003bc;M</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">H1975 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>17/18/19</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduce the expressions of Akt, EGFR, and the active forms of Akt, EGFR, Erk, and Stat3 (Hsp90 client oncoproteins) [<xref rid="B38-biomolecules-13-01191" ref-type="bibr">38</xref>].</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Anti-quorum sensing activity<break/>(0.2 mg/mL)</td><td align="center" valign="middle" rowspan="1" colspan="1">Inhibiting the production of violacein in <italic toggle="yes">Chromobacterium violaceum</italic> CV026</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<bold>35</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">67%</td><td align="center" valign="middle" rowspan="1" colspan="1">80% in 0.05 mg/mL</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Pro: Strong activity [<xref rid="B56-biomolecules-13-01191" ref-type="bibr">56</xref>,<xref rid="B57-biomolecules-13-01191" ref-type="bibr">57</xref>].</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduction in elastase activity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">40%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">49% in 0.05 mg/mL</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Brine shrimp lethality (LD<sub>50</sub>, &#x003bc;M)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>36</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Con: Medium activity [<xref rid="B60-biomolecules-13-01191" ref-type="bibr">60</xref>].</td></tr><tr><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Antifouling activity</td><td align="center" valign="middle" rowspan="1" colspan="1">Anti-diatom attachment activity</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>36</bold> (50 &#x000b5;g/mL)</td><td align="center" valign="middle" rowspan="1" colspan="1">85%</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Pro: Strong activities of <bold>36</bold> and <bold>42</bold> [<xref rid="B62-biomolecules-13-01191" ref-type="bibr">62</xref>,<xref rid="B76-biomolecules-13-01191" ref-type="bibr">76</xref>]. Con: Weak activities of <bold>38</bold> and <bold>40</bold> [<xref rid="B72-biomolecules-13-01191" ref-type="bibr">72</xref>,<xref rid="B73-biomolecules-13-01191" ref-type="bibr">73</xref>].</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">Balanus amphitrite</italic> (EC<sub>50</sub>)</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>38/40</bold> (mM)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.28/0.10</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cyprid larvae of the barnacle (LC<sub>50</sub>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>42</bold> (&#x003bc;g/mL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.5 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Antioxidant activity, DPPH free radical scavenging</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ABTS<sup>+&#x02022;</sup> scavenging capacity at 2 mg/mL</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>36</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">54.6 &#x000b1; 0.6%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">79.1 &#x000b1; 4.3% at 0.16 mg/mL</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Con: Medium or weak activities [<xref rid="B41-biomolecules-13-01191" ref-type="bibr">41</xref>,<xref rid="B61-biomolecules-13-01191" ref-type="bibr">61</xref>,<xref rid="B74-biomolecules-13-01191" ref-type="bibr">74</xref>].</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OH<sup>&#x02022;</sup> inhibition at 2.5 &#x003bc;M</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>38/40</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">64.9%/54.1%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IC<sub>50</sub> (&#x003bc;g/mL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>48</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">240.05</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16.87</td></tr></tbody></table><table-wrap-foot><fn><p>The bold bioactive values are stronger than their positive controls.</p></fn></table-wrap-foot></table-wrap></floats-group></article>